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ABSTRACT 
We hypothesize rumen-protected arginine supplementation during gestation will mitigate 
deleterious offspring effects caused by undernutrition. Experiment 1: non-pregnant ewes were 
supplemented with rumen-protected arginine at varying doses to assess effects on circulating 
amino acids and carotid hemodynamics. Arginine concentrations post-supplementation were 
greater in ewes supplemented with 180 vs. 90 mg/kg BW, and vascular resistance indices were 
lesser with 180 mg/kg BW; therefore, 180 mg/kg BW was used in experiment 2. Experiment 2: 
nutrient-restricted pregnant ewes were supplemented with rumen-protected arginine and 
maternal and offspring growth and physiological responses were measured. Arginine 
supplementation to nutrient restricted ewes improved offspring development compared to 
restricted ewes without supplementation. Circulating amino acids in offspring were efficiently 
metabolized, which may contribute to improved growth and development. There was no change 
in carotid hemodynamics in supplemented pregnant ewes. Further research should determine 
how arginine improves development, as this dietary supplement could rescue at-risk pregnancies.  
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
 
Introduction 
Fetal growth restriction (FGR) in utero, or intrauterine growth restriction (IUGR), can be 
defined as any impairment to growth and development of the fetus.  A major cause of 
FGR/IUGR is inappropriate maternal nutrition (Wu et al., 2006; Caton and Hess, 2010). Poor 
maternal nutrition during gestation may permanently defect the structure and physiology of 
vascular development of the fetus. If undernutrition continues into late pregnancy, fetal amino 
acid metabolism may shift to the placenta for energy production, causing amino acids normally 
destined for the fetus to be catabolized by the placenta for energy (Barker et al, 1993).  We 
believe that arginine supplementation may be a solution to “rescue” at risk offspring from 
compromised maternal nutrition during pregnancy.  
Arginine is the most abundant carrier of protein nitrogen (N) in animals, and has been at 
the center of amino acid research for many years (Flynn et al., 2002). Arginine is classified as a 
semi-essential amino acid, meaning that the body is able to synthesize it, but at certain 
physiological states the body isn’t able to synthesize enough to meet requirements. Times of 
critical arginine demand and likely elevated conditional requirements include growth and 
catabolic states, along with health challenges involving trauma, burn injury, massive small-bowel 
resection, and renal failure (Cynober, 1994; Flynn et al., 2002). 
Supplementation of amino acids to ruminants is more complex than to monogastrics due 
to the microbial population present in the rumen. To alleviate this challenge, past researchers 
have used jugular (Recabarren et al., 1996) or abomasal (Davenport et al., 1990) infusion 
technologies to deliver arginine to ruminants for absorption, however these infusion techniques 
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are not practical for everyday production purposes. Rumen-protection technologies have been 
utilized to make dietary amino acid supplements protected from microbial degradation and 
available for absorption in the small intestine in ruminants (Oke et al., 1986).  These rumen-
protected supplements can be fed along with a normal ration, so it is much more practical for 
producers to implement.  By using these rumen-protected amino acids, a producer can be more 
confident that their ruminant animal is receiving the amino acid they are administering them. 
However, it is essential that a producer knows that they are administering the most effective 
dose, both for the physiological benefit of the animal, and for the economic benefit of the 
producer. One of the objectives of this study will be to determine the most effective dose at 
which to administer a dietary rumen-protected arginine supplement to gestating ewes. 
Once the most effective dose is established, we seek to examine whether arginine 
supplementation is affecting related amino acid balance in both the dam and her offspring, 
despite the fact that the offspring aren’t receiving the arginine supplement directly. Our main 
objective in supplementation is to test whether dams receiving arginine during gestation will 
benefit their subsequent offspring despite effects of inappropriate maternal nutrition during 
pregnancy. We believe these effects may, at least partially, be achieved through enhanced blood 
flow during gestation induced by arginine supplementation. 
 
Fetal growth restriction and maternal nutrition 
Inappropriate maternal nutrition is a relevant concern in livestock production. For 
example, in the Western United States, grazing ewes can often receive less than 50% of their 
nutrient requirements during times of summer drought or winter dormancy (Wu et al., 2006).  
Nutrient restrictions of this magnitude are documented to cause IUGR (Meyer et al., 2010; 
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Swanson et al., 2008). Not surprisingly, maternal condition during gestation is impacted by 
inappropriate nutrition. Meyer et al. (2010) found that ewes fed a restricted diet (60% of 
requirements) lost weight from day (d) 39 to 95 of gestation, while ewes on adequate nutrient 
diets (100% of requirements) gained weight. From d 96 through term of gestation restricted ewes 
gained markedly less weight than ewes receiving adequate nutrients. These changes were also 
reflected in ewe body condition score (BCS); restricted nutrient ewes lost condition from d 39 to 
95 of gestation while ewes receiving adequate nutrition gained condition.  
In addition to a loss of ewe body weight during pregnancy, ewes can demonstrate 
reduced lactation performance which will impact future neonatal and postnatal growth (Wu et 
al., 2006).  In a similar study to the aforementioned, ewes restricted in nutrients yielded less 
colostrum than ewes fed adequate nutrients throughout pregnancy; these results continued into 
early lactation when those restricted ewes continued to produce less milk than adequately fed 
ewes (Meyer et al., 2011a). This means that in addition to impaired neonatal development, 
offspring will be receiving inadequate postnatal nutrition; this contributes to the overall 
challenge of postnatal healthy life and survival. 
Implications of IUGR in offspring will often manifest as low birth weights and pre-
weaning deaths (Wu et al., 2006).  Undernutrition during the last one-third of gestation is 
particularly detrimental to fetal development, as this is the window in which most fetal growth 
occurs in ruminants (Caton and Hess, 2010). Most pre-weaning deaths of offspring in the United 
States occur within the first days of postnatal life (Wu et al., 2006). The offspring that survive 
the first few days of life are more prone to have neurological, respiratory, intestinal, and 
circulatory disorders.  All of these effects result in a longer period of time required to adapt to 
postnatal life (Wu et al., 2006; Caton and Hess, 2010; Reynolds and Caton, 2012). In the sheep 
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industry lamb loss is a major issue, making the ability of offspring to adapt to postnatal life 
rapidly all the more important; most lamb deaths occur before reaching the age of being marked, 
docked, or branded (USDA 2012). In the aforementioned study, Meyer et al. (2010) found that 
offspring from ewes receiving restricted nutrients during gestation had 8.1% lower birth weights 
than offspring from ewes receiving adequate nutrients. Offspring from ewes receiving restricted 
nutrients continued to weigh less at various early stages of life, which resulted in decreased ADG 
as compared to those offspring from adequately fed dams. Restricted offspring also had lower 
heart girth measurements than offspring from ewes receiving adequate nutrients. A combination 
of all of these traits could seriously impair the ability for offspring to develop normally and have 
a healthy life.  
 
Arginine metabolism, absorption, and interactions 
Arginine metabolism 
Metabolism of arginine is initiated when dietary protein is broken down to its 
components by proteolytic enzymes. Pancreatic enzymes trypsin and carboxypeptidase B are 
proteolytic enzymes that release arginine and lysine (Grimble, 2007). We would expect that 
dietary arginine supplementation could potentially up-regulate activity of these pancreatic 
enzymes. 
 Arginine synthesis is often characterized as the “intestinal-renal axis”, because this 
process takes place first in the intestine and eventually in the kidney (Morris, 2007). Citrulline is 
synthesized in the enterocyte and enters the bloodstream to travel to the kidney, where 
arginosuccinate will convert the citrulline to arginine (Cynober et al., 1995; Wu et al., 2009). 
Unlike the liver, the kidney is practically devoid of arginase activity so arginine synthesis can 
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actually result in net arginine accumulation (Flynn et al., 2002). This conversion of citrulline to 
arginine takes place in many cell types other than enteroctyes, including adipocytes, endothelial 
cells, macrophages, neurons, and myocytes. However, the kidney appears to be a primary driver 
of arginine synthesis from citrulline (Wu et al., 2009).  
Arginine synthesis in the liver due to the urea cycle does occur; however, due to large 
amounts of arginase in the liver there is no net accumulation (Cynober et al., 1995). Arginine 
serves as an allosteric activator to N-acetylglutamate synthetase, which would synthesize N-
acetylglutamate. This N-acetylglutamate is an activator of carbamoyl phosphate synthetase, 
which is a key enzyme in the urea cycle (Cynober et al., 1995; Cynober, 2002). Therefore, 
greater amounts of arginine will allosterically increase ureagenesis in the liver. This may 
partially explain why higher protein diets often stimulate increased ureagenesis, and indicates 
that supplemental dietary arginine would probably induce a similar effect. 
Arginase enzymes are the primary drivers of arginine degradation. Arginases convert 
arginine to ornithine, which causes downstream synthesis of proline, glutamate, glutamine, and 
polyamines. Arginases can be type I or type II; type I arginases are primarily used by the liver 
for the urea cycle, while type II arginases are located in the kidney, brain, small intestine, 
endothelial cells, mammary gland, and macrophages (Flynn et al., 2002). Another key product of 
arginine catabolism is creatine. Creatine synthesis occurs by arginine:glycine amidinotransferase 
(AGAT) transferring the guanidine group from arginine to the amino group of glycine to yield 
guanidinoacetate. Guanidinoacetate is later methylated to eventually become creatine (Wu et al., 
2013). 
Arginases compete for arginine with another family of enzymes: nitric oxide synthases 
(NOS; Wu et al., 2009). Arginine provides the N atom for nitric oxide (NO) in its reaction with 
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these NOS enzymes (Morris, 2007). The NOS enzymes include three families: eNOS, which is 
present in endothelial cells, nNOS, which is present in neuronal tissue, and iNOS, which are 
inducible by cytokines under certain immune conditions. Collectively, the NOS enzymes require 
arginine, O2, tetrahydrobiopterin (BH4), nicotinamide adenine dinucleotide phosphate 
(NADPH), calmodulin, flavin mononucleotide (FMN), and flavin adenine dinucleotide (FAD) 
to produce NO; BH4 is the rate-limiting cofactor (Cynober et al., 1995; Wu et al., 2009). The 
iNOS family produces the greatest amount of NO, which is used for immune function (Flynn et 
al., 2002). The NO produced by iNOS has been used to fight tumor cells through 
glyceraldehyde-3-phosphate dehydrogenase, aconitase, nicotinamide adenine dinucleotide 
(NADH)-ubiquinone oxidoreductase, and succinate-ubiquinone oxidoreductase inhibition to 
impair cellular respiration (Cynober et al., 1995). Increased interest has centered on eNOS 
production of NO, and its role in vasodilation to regulate blood flow and vascular tone (Martin et 
al., 2001). This NO released by eNOS activates guanylyl cyclase, which increases cellular cGMP 
levels to induce smooth muscle relaxation (Cynober, 1994).  
A key question often posed in arginine supplementation is ‘how much is too much’, at 
what point are the NOS enzymes reaching saturation? Considering the Km of NOS is 5 µm and 
under normal conditions endothelial cellular arginine concentrations are somewhere around 100 
times greater than this, it seems that these enzymes are probably almost always saturated with 
substrate. However, it appears that NOS is co-localized with arginine transporters in the plasma 
membrane. This suggests that some arginine is going to its transporter to enter the intracellular 
arginine pool for later use, however arginine could rather be preferentially sent to NOS to be 
used for NO production (Cynober, 2002). 
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Arginine can also be degraded by arginine decarboxylase to agmatine; this reaction takes 
place in the brain, liver, kidney, adrenal gland, macrophages, and the small intestine. Agmatine 
will then be converted to putrescine, a polyamine, by agmatinase (Flynn et al., 2002). 
Polyamines serve many functions, including protecting cells from oxidative damage, regulating 
gene expression, signal transduction, ion channel function, DNA and protein synthesis, and 
apoptosis. Polyamines are essential for cell proliferation, differentiation, and function (Flynn et 
al., 2002). These functions make them especially important during periods of growth and 
development, including fetal development during gestation. Polyamines are also required in 
blastocyst implantation, and are therefore important in achieving pregnancy (Wu et al., 2013).  
 
Arginine absorption and transport 
Absorption and transport of arginine will be indicative of its further metabolism and 
interaction with amino acids. Intestinal absorption of arginine in mammals takes place in the 
ileum and jejunum by both transporters and physical diffusion components. Physical diffusion 
takes place at high arginine concentrations, and can represent up to 45% total arginine uptake 
(Cynober et al., 1995). At the brush border of the intestine there are several arginine transporters 
present, including B
0,+
 (Na
+
-dependent) and b
0,+
 (Na
+
-independent). These transport systems are 
primarily found in fibroblasts and endothelial cells, and are shared with lysine, ornithine, and 
cysteine (Cynober et al., 1995). In addition, peptide transporter 1 (PEPT1) would be present at 
the brush border to transport arginine present in peptide forms.  
Finally, y
+
 is a primary arginine transport system present at both the brush border and in 
the basolateral membrane. This is a high affinity, pH-insensitive, Na
+
-independent basic amino 
acid transporter with a steric constraint that will not permit methylated forms of amino acids to 
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bind (Cynober et al., 1995). The y
+
 transporter is stimulated by intracellular arginine 
accumulation (Morris, 2007). This transporter is shared with lysine, histidine, and ornithine, 
which can cause concern during arginine supplementation (Flynn et al., 2002; Wu et al., 2009). 
Note that this transporter is not used by citrulline, and therefore citrulline does not compete with 
arginine for transport. Most of the dietary arginine taken up by the intestine will be released as 
citrulline, or metabolized in the liver (Cynober et al., 1995). 
 
Peptides     
ARGININE 
PEPT1 
 
 
 
y
+
 
Basolateral membrane 
 
Figure 1.1. Intestinal absorption and transport of arginine. Arginine can be absorbed by more 
general transporters, including b
0,+
 and B
0,+
, or by more specific transporters like y
+
. The y
+
 
transporter absorbs arginine at both the brush border and the basolateral membrane. Adapted 
from Cynober et al., 1995. 
 
Interaction between arginine and other amino acids 
Citrulline. The relationship between arginine and citrulline is complex and intriguing. 
Arginine can be both metabolized to and synthesized from citrulline in enterocytes and the 
kidneys, as mentioned previously. Low protein diets will cause animals to down-regulate 
arginine flux to the liver in order to spare the arginine from degradation in ureagenesis. Instead, 
y
+
  b
0.+
  B
0.+
 Intestinal Brush Border 
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the arginine will be metabolized into citrulline in the small intestine, which will be sent to the 
kidney for arginine synthesis. This is an arginine-sparing effect because citrulline is not 
metabolized in the gut and will not compete for arginine transporters (Cynober, 2002). Very little 
citrulline goes to the liver for metabolism; most will be transported to the kidney. For these 
reasons, citrulline has been implicated as a better precursor for arginine than ornithine (Cynober 
et al., 1995). Citrulline supplementation has been shown to increase plasma arginine, and 
bioavailability between the three amino acids (citrulline, arginine, and ornithine) is greatest in 
citrulline, followed by ornithine and arginine, respectively (Cynober, 2007). Based on this 
information, we would hypothesize that citrulline levels would increase with arginine 
supplementation. With no competition for intestinal absorption transporters, citrulline would 
readily be synthesized from the increased amounts of arginine in the small intestine. If protein 
supply was not reduced, we believe less citrulline would eventually be used for arginine 
synthesis in the kidney because the body would not require arginine synthesis due to its adequate 
or increased arginine status. 
Ornithine. Like citrulline, ornithine is also synthesized from arginine in the gut. This 
conversion is performed by arginase enzymes (Cynober, 2002). Ornithine can be further 
metabolized to putrescine, which can form spermidine and spermine downstream, all of which 
are polyamines (Flynn et al., 2002). Ornithine can also generate glutamine via ornithine 
aminotransferase, citrulline via ornithine carbamoyl transferase, and proline. Most of the 
ornithine generated from arginine will enter the portal bloodstream to travel to the liver and 
participate in ureagenesis; only a small fraction will eventually synthesize polyamines (Cynober 
et al., 1995). Unlike arginine, ornithine has a nitrogen-sparing effect; when ornithine is combined 
with 2NH4
+
 it synthesizes arginine, whereas arginine generates urea to utilize N (Cynober, 2007). 
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In its α-ketoglutarate salt form, OKG, ornithine works to regulate N balance during malnutrition 
(Cynober, 1994). Ornithine may also work with arginine to improve immune response to 
inflammation. Activated macrophages synthesize NO and release arginase around inflammatory 
site upon their lysis. Arginine would convert to ornithine via these arginases, and ornithine 
would be transported to lymphocytes for polyamine synthesis. Also, ornithine could generate 
proline for collagen synthesis (Cynober et al., 1995). Considering the relationship between 
ornithine and arginine, we would anticipate that arginine supplementation would increase 
ornithine due to up regulated arginase activity. We would also expect polyamine synthesis to 
increase, which would normally be beneficial to the animal. Because supplemental arginine 
would most likely increase ureagenesis activity, we would expect the majority of the increased 
ornithine levels to be shuttled to the liver to participate in the urea cycle. 
Lysine. In contrast to citrulline and ornithine, lysine is not synthesized from arginine but 
is thought to antagonize arginine transport and mobilization for metabolism. Antagonism in 
transport is due to competition for use of the y
+
 transport system and its potential saturation. 
Antagonism in arginine mobilization for metabolism is hypothesized to be due to inhibition of 
trypsin and carboxypeptidase B, either at the intestinal action level or the pancreatic synthesis 
level, to decrease arginine availability for further metabolism (Jones et al., 1967). The results in 
experiments testing this antagonism are mixed. In young pigs, reduced growth was seen 
accompanying lysine supplementation, but this was thought to be due to a shift causing amino 
acid imbalance as opposed to simply arginine antagonism (Edmonds and Baker, 1987). 
However, in tissue culture lysine has been successful in suppressing negative immune 
consequences of arginine and herpes simplex virus (Griffith et al., 1981). The chick is the animal 
model in which most lysine-arginine research has been conducted, because chicks cannot 
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synthesize arginine to correct the antagonism caused by lysine. Adding excess L-lysine to the 
diet of chicks increases the requirement for arginine. If this requirement is not met, chicks will 
exhibit decreased growth rate, symptoms of arginine deficiency, and decreased plasma arginine 
concentrations. All of these symptoms are able to be reversed with arginine supplementation 
(Jones, 1964; Jones et al., 1967). Studies examining transporter saturation in the chick have 
found that transporter competition is not very significant (Jones et al., 1967). Plasma-to-muscle 
ratios of lysine:arginine were not altered by high dietary lysine concentrations. In addition, 
though plasma concentrations of lysine were high, urinary arginine losses did not change. 
Studies in the chick that tested pancreatic enzyme availability to metabolize arginine have been 
inconclusive and not very repeatable. Therefore, performance differences caused by lysine 
supplementation were believed to be due to decreased tissue arginine concentrations and a 
delayed response in kidney arginase activity (Jones et al., 1967). All of this data could indicate 
that lysine-arginine antagonism is more easily seen in vitro than in vivo. Performance changes in 
vivo due to lysine supplementation are more likely due to amino acid balance shifts than a 
specific arginine antagonism effect. Also, since the chick is one of the few animals incapable of 
producing any arginine, most animals would be able to “override” antagonism effects induced by 
lysine by mobilizing citrulline to synthesize more arginine. We believe that arginine 
supplementation would, therefore, not impact lysine concentrations present in the blood stream 
due to antagonism in mammals. 
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Figure 1.2. Relationships between arginine and related amino acids and metabolites. Adapted 
from Flynn et al., 2002. Nested within this figure is the urea cycle (Citrulline  Arginosuccinate 
 Arginine  Ornithine); urea is synthesized in the arginase-catalyzed reaction of arginine  
ornithine. Note that studies have shown that agmatine may also have a direct pathway to 
polyamine synthesis via an intermediate between arginine and putrescine (Wang et al., 2014). 
 
The role of dietary arginine in maternal and fetal tissue development during gestation 
 Nitric oxide and polyamines play important roles in fetal growth and development: nitric 
oxide as a vasodilator (Martin et al., 2001) and polyamines to regulate DNA and protein 
synthesis, cell proliferation and differentiation, regulation of gene expression, and signal 
transduction (Kwon et al., 2003). Placental angiogenesis and vascular growth are stimulated by 
NO.  This could serve to provide more blood to the placenta, which would carry increased 
nutrients to support fetal development during gestation.  Other reproductive processes that 
require NO include ovulation and embryonic development and implantation (Wu et al., 2013).  
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Polyamines are also required in blastocyst implantation (Wu et al., 2013). All of this suggests the 
importance of arginine during fetal conception and development. Encouraging the importance of 
arginine to young animals, data further suggests that arginine requirements of young piglets are 
greater than current NRC recommendations reflect (Kim et al., 2004). This poses the question: is 
this difference in requirement only present in piglets or in more young species, including 
ruminants? 
 Supplementation of arginine directly to young offspring has been shown to have 
beneficial effects in monogastrics. Yao et al. (2011) found that dietary arginine supplementation 
to weaned piglets enhanced daily BW gain, feed efficiency, and relative small intestinal weights. 
Maternal supplementation during pregnancy has been another documented method of 
supplementing arginine to offspring in utero. Mateo et al. (2007) provided arginine as a dietary 
supplement to pregnant sows from d 30 of gestation through parturition. Their findings 
demonstrated ability for arginine to increase both litter size and live litter birth weights in piglets. 
In a similar study, Gao et al. (2012) found that dietary arginine supplementation to pregnant 
sows increased total number of piglets per litter, number of live born piglets, litter birth weight, 
and placental weights. This data strongly suggests that dietary arginine supplementation has both 
neonatal and postnatal beneficial effects on offspring. However, as previously mentioned, dietary 
supplementation to monogastrics does not present the same challenges as to ruminants 
Often in ruminants, arginine and other amino acids are provided as infusions. Several 
studies have been done involving intravenous injection of arginine to ewes on either control 
(100% NRC nutrient requirements) or restricted (less than 100% NRC nutrient requirements; 
often between 50 and 60% requirements) diets.  Lassala et al. (2010) found that injection of 
arginine from d 60 to term of gestation increased birth weights of lambs from restricted ewes by 
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21% as compared to saline-injected restricted ewes. Satterfield et al. (2013) found that after 
injecting arginine vs. saline to ewes receiving 100% NRC requirements or 50% NRC 
requirements, weights of lambs were unaffected by arginine treatment. However, Satterfield 
injected arginine for only 25 days (d 100 to 125 of gestation) during pregnancy.  
Based on previous research from our lab, we hypothesize that rumen-protected arginine 
supplementation will provide a more steady-state metabolism than injection of arginine. Injection 
of arginine induces a short-term spike in bioavailability, while steady dietary supplementation 
over time seems to be more consistently bioavailable in the serum (A. M. Meyer, C. B. Saevre, 
D. V. Dhuyvetter, R. E. Musser, and J. S. Caton, unpublished data). For this reason, we are 
seeking to establish a proven supplementation protocol using rumen-protected arginine instead of 
arginine injections. We hypothesize that we will see similar or enhanced results as compared to 
previous studies using arginine infusions.  
 
The effects of arginine on hemodynamic responses during gestation 
It has been long known that blood circulation plays vital roles in fetal development 
during gestation. Blood flow to the placenta undergoes massive shifts throughout stages of 
gestation (Rosenfeld et al., 1974). In 1977, Rosenfeld measured blood flow to several organs in 
ewes throughout gestation, including the brain, pancreas, spleen, heart, liver, kidneys, adrenals, 
uterus, and mammary gland. In these ewes heart rate increased by 20% as gestation progressed, 
while cardiac output increased by a marked 75%. Throughout gestation, blood flow to the brain, 
liver, and kidneys decreased, while blood flow to the uterus increased as a percentage of total 
cardiac output (Rosenfeld et al., 1977). These data help to illustrate the important role blood flow 
and its distribution has during gestation. 
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In compromised pregnancies, such as those caused by inappropriate maternal nutrition, 
these trends in blood flow may shift inappropriately. The placenta is the major organ for nutrient 
exchange between mother and fetus, and blood flow mediates much of these exchanges. The 
blood flow via uterine vessels feeds the maternal portion of the placenta, while blood flow via 
umbilical vessels feeds the fetal portion of the placenta; both uterine and umbilical blood flows 
increase throughout progression of pregnancy (Reynolds et al., 2006). However, pregnancies 
with risk of reduced fetal and placental growth often present reduced rates of placental blood 
flow and reduced fetal nutrient uptake. These compromised pregnancies may be susceptible to 
nutritional therapies to counteract these blood flow effects. For example, ewes in a compromised 
pregnancy model that were fed high dietary selenium displayed an increase in placental 
vascularity (Reynolds et al., 2006). 
Arginine may be a nutritional therapeutic to increase blood flow to possibly counteract 
defects in compromised pregnancies. Altered eNOS expression can alter placental vascular 
development, and low levels of placental eNOS have been associated with IUGR pregnancies. In 
addition, NO may interact with vascular endothelial growth factor (VEGF: an indicator of 
vascularity) to further impact fetal growth (Reynolds et al., 2006). 
 In a 4 × 4 Latin square experiment, Meyer et al. (2011b)  supplemented steers with one of 
two dietary doses of rumen-protected arginine (180 or 360 mg/kg), an injectable arginine 
supplement, or no supplementation at all. Hemodynamics were measured via Doppler 
ultrasonography at the carotid artery. Their findings showed that steers receiving 180 mg/kg BW 
of rumen-protected arginine had greater distal tissue perfusion than those steers receiving no 
supplement at all, or those supplemented with injectable arginine (Meyer et al., 2011b). In 
addition, steers receiving 180 mg/kg BW of rumen-protected arginine had decreased vascular 
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resistance compared to those steers receiving no supplement at all, or those supplemented with 
360 mg/kg BW of rumen-protected arginine (Meyer et al., 2011b). These data suggest that 
rumen-protected arginine supplementation may enhance blood flow. However, further studies 
need to be performed in pregnant animals to test the effects during gestation. We hypothesize 
that arginine supplementation to pregnant animals will induce similar effects, and improve 
vascular hemodynamics throughout gestation. 
 
The effects of arginine on intestinal characteristics in young animals 
 Intestinal health is often examined as an indicator of increased growth, as the intestine is 
the primary organ of nutrient absorption and initiation of nutrient assimilation. Several studies 
have evaluated the effect of arginine supplementation on intestinal characteristics in young 
animals. Zhan et al. (2008) fed arginine supplement to early weaned piglets, and found that 
supplementation increased villus height in the small intestine. In addition, VEGF showed 
increased immunoreactive expression in the duodenum, jejunum, and ileum, suggesting 
increased vascularity to these portions of the organ. This study found dose dependent effects: the 
lower dose of arginine supplementation induced an increase in VEGF expression as compared to 
control, but the higher dose did not. This further illustrates the imperative nature of administering 
the most efficient dose to illicit desired effects.  
In a similar study, Yao et al. (2011) also found that arginine supplementation up until 21 
d of age, weaned piglets had increased villus height and VEGF protein levels in the duodenum, 
ileum, and jejunum. These data support a potential role for arginine supplementation in increased 
intestinal health. We will examine intestinal health by studying jejunal characteristics of 
offspring from arginine-supplemented dams. We hypothesize that these offspring will express 
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characteristics that reflect better intestinal health and therefore potential for enhanced nutrient 
absorption and assimilation. 
 
Conclusions 
Arginine should be examined as a potential therapeutic for at-risk pregnancies due to 
maternal undernutrition through strategic supplementation that will be provided in concentrations 
that will be transported and utilized by the body without negatively impacting related amino acid 
metabolism. If this is achieved, arginine can potentially increase blood flow to the fetus during 
gestation to increase nutrient availability for development. Also, maternal supplementation of 
arginine during gestation could improve gut health of the offspring, and further aid in nutrient 
assimilation. Based on these priorities and previous research in our lab, we believe that a dietary 
rumen-protected arginine supplement at a specified dose will accomplish these goals most 
efficiently in pregnant ewes, and result in healthier, more viable lambs 
. 
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CHAPTER 2. DOSE TITRATION OF RUMEN-PROTECTED ARGININE IN 
EWE LAMBS: EFFECTS ON CAROTID ARTERIAL HEMODYNAMICS 
AND CIRCULATING SERUM AMINO ACIDS 
 
Abstract 
Our hypothesis was that rumen-protected arginine supplementation would impact 
concentrations of arginine-related serum amino acids in non-pregnant ewes. This would increase 
concentrations of amino acids resulting from the metabolism of arginine (citrulline, ornithine), 
and decrease levels of amino acids competing for transporters with arginine (lysine). We further 
hypothesized that arginine supplementation would increase blood flow by inducing vasodilation 
via nitric oxide production. To test these hypotheses, non-pregnant primiparous Rambouillet ewe 
lambs (n = 60) were penned individually in a temperature-controlled facility for a dose titration 
study to determine the most effective dose of rumen-protected arginine to positively influence 
both circulating amino acids and blood flow. Ewes were randomly assigned to one of four 
treatments: a control group receiving no supplement (CON), and groups receiving 90 mg/kg BW 
(90), 180 mg/kg BW (180), or 360 mg/kg BW of rumen-protected arginine supplement (360). 
Supplements were administered for 15 d, and fully consumed before delivery of a total pelleted 
diet. Blood samples were attained at 0600 on d 5, 8, 12, and 15 of the treatment period. In 
addition, Doppler ultrasound was used to assess carotid arterial blood flow on d 5, 8, 12, and 15 
of the supplementation period. After 15 d of supplementation, ewes receiving 180 mg/kg BW of 
rumen-protected arginine had greater serum ornithine (P = 0.05) and arginine (P = 0.05), and 
tended to have greater aspartate (P = 0.08) than ewes receiving 90 mg/kg BW, and 180 were 
similar to 360 fed ewes (P ≥ 0.55). All ewes receiving arginine supplement (90, 180, and 360) 
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had greater distal tissue perfusion than CON ewes (P = 0.02). Ewes receiving 90 or 180 mg/kg 
BW of arginine supplement showed the least resistance of blood flow (P = 0.01). Based on these 
serum amino acid data and blood flow analyses, we accept our hypothesis that arginine 
supplementation will impact serum amino acid concentrations and blood flow. In addition, we 
determine 180 mg/kg BW to be the most effective dose at which to administer this rumen-
protected arginine supplement. 
 
Introduction 
Using strategic arginine supplementation to improve various aspects of livestock 
production has been a promising area of research for many years. Much of this research has been 
done in monogastrics, where provision of arginine has shown positive impacts on early 
embryonic survival in rats (Zeng et al., 2008), and increased fetal survival and litter sizes in 
swine (Mateo et al., 2007).  
Due to amino acid breakdown by microbes in the rumen, dietary amino acid 
supplementation in ruminants requires direct intravenous injection, postruminal infusion, or use 
of a protection agent to permit the amino acid to be absorbed for metabolism in the small 
intestine. Lassala et al. (2010) found that arginine injection in pregnant ewes resulted in 
enhanced lamb birth weights from nutrient restricted dams. In a further experiment, Lassala et al. 
(2011) found that arginine improved fetal survival in dams carrying multiple fetuses. Because 
dietary supplementation of arginine is more practical in livestock production than intravenous 
injections and postruminal infusions, our research strategy focused on effects of feeding rumen-
protected arginine supplement. 
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Arginine supplementation has been shown to increase circulating arginine and ornithine 
concentrations, both in monogastrics (Southern and Baker, 1982) and via protection agents in 
ruminants (Meyer et al., 2011a). Ornithine often follows similar circulation patterns to arginine 
because arginases commonly break down arginine into ornithine, which can be used either in the 
urea cycle or to synthesize polyamines. In contrast, arginine supplementation has been 
hypothesized to decrease circulating lysine and/or histidine due to competition for a common y
+ 
transporter at the brush border and basolateral membrane (Cynober et al., 1995; Flynn et al., 
2002). However, results regarding this antagonism effect between arginine, lysine, and histidine 
are mixed. This antagonism is more pronounced in poultry, due to their inability to synthesize 
arginine to compensate for reduced transport caused by lysine supplementation (Jones et al., 
1967). In contrast, young pigs fed dietary arginine in excess did not see a change in circulating 
lysine or histidine (Southern and Baker, 1982). However, an antagonism effect between arginine 
and lysine has been reported using rumen-protected arginine supplementation in steers, most 
notably in supplementation of greater concentrations (Meyer et al., 2011a). We hypothesized that 
due to arginine supplementation, we would note an increase in circulating ornithine and 
citrulline, in addition to a decrease in circulating lysine. 
In addition to its amino acid interactions, arginine serves as a substrate for NOS enzymes, 
which in turn synthesize NO (Wu et al., 2009; Wu et al. 2013). Nitric oxide is a known 
vasodilator, which increases blood flow by regulating vascular tone (Martin et al., 2001). 
Because the carotid artery is one of the first major vessels leaving the aorta, the carotid artery can 
be used as an indicator for systemic blood flow. Rumen-protected arginine supplementation has 
been shown to influence carotid arterial hemodynamics by increasing distal tissue perfusion and 
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decreasing resistance in the vessel (Meyer et al. 2011b). We hypothesized that arginine 
supplementation would increase blood flow due to increased NO production. 
 
Materials and methods 
Protocols described herein were approved by the North Dakota State University 
Institutional Animal Care and Use Committee. Nulliparous Rambouillet-cross ewe lambs (n = 
60; 51 ± 1.4 kg initial BW) from NDSU Hettinger Research Extension Center were housed 
individually in a temperature-regulated facility (12 to 21°C; Animal Nutrition and Physiology 
Center; Fargo, ND) with free access to water. Facility lighting was timed to mimic normal 
daylight patterns. 
 
Experimental design and treatments 
All ewes were designated a complete pelleted diet (Table 2.1) fed twice daily (0630 and 
1830) to meet NRC (1985, 2007) recommendations. Dietary intake for each individual ewe was 
calculated based on BW and metabolizable energy (ME) requirements. Diets were analyzed for 
dry matter (DM), ash, and crude protein (CP) following the Association of Official Agricultural 
Chemists (AOAC; 1990), and neutral detergent fiber (NDF) and acid detergent fiber (ADF) 
using an Ankom Fiber Analyzer (Ankom Technology, Fairport, NY).  
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Table 2.1. Ingredient and nutrient composition of pelleted diet fed to ewes
1 
Item % 
Ingredient  
     Alfalfa meal, dehydrated 34.0 
     Beet pulp, dehydrated 27.0 
     Wheat middlings 25.0 
     Ground corn 8.4 
     Soybean meal 5.0 
     Trace mineral premix
2 
0.6 
Nutrient composition  
     DM 89.9 
     CP 15.5 
     NDF 37.2 
     ADF 21.5 
1
Diets administered to ewes daily at 0630 and 1830. 
2
Premix: 18 to 21% Ca, 9% P, 10 to 11% NaCl, 49.3 mg/kg Se, 700,000 IU/kg Vitamin A, 200,000 IU/kg 
Vitamin D, 400 IU/kg Vitamin E 
 
In addition to this pelleted diets ewes were randomly assigned either 0, 90, 180, or 360 
mg rumen-protected arginine (RP-ARG; Kemin Industries, Des Moines, IA) per kg BW (based 
on initial BW); Arginine was mixed with 50 g of fine ground corn and fed twice daily prior to 
offering the pelleted diet. Control ewes (0 mg/kg RP-ARG) were also provided 100 g of fine 
ground corn daily, without the added rumen protected arginine. This resulted in four treatment 
groups consisting of 0 mg/kg (CON, n = 15), 90 mg/kg (90, n = 15), 180 mg/kg (180, n = 15), 
and 360 mg/kg (360, n = 15) BW RP-ARG in addition to a complete pelleted diet. A 7 d 
adaptation period to the pelleted diet was implemented before beginning rumen-protected 
arginine treatments; treatment period continued for a total of 15 d. Ewe BW and BCS was 
measured at initiation (d 0) and end (d 15) of 15 d treatment period. Body condition score was 
measured on a 1 to 5 scale (1 = emaciated and 5 = obese) by two independent evaluators. 
 
Blood sample collection and analysis 
Blood samples were attained at 0600 on d 5, 8, 12, and 15 of the treatment period. 
Collections were obtained via right jugular venipuncture so as to avoid puncturing the left carotid 
27 
 
artery, which was used for Doppler ultrasonography. Blood (10 mL) was collected with Corvac 
serum separator vacuum tubes with thrombin (Tyco Healthcare, Mansfield, MA), which were 
placed on ice and held a minimum of 45 minutes. Whole blood was centrifuged at 1,500 × g for 
30 min at 4°C, after which supernatant was pipetted into 2-mL screw-cap vials and stored at  
-20°C.  
Serum AA concentrations were evaluated using ultra performance liquid chromatography 
(UPLC) methods similar to Meyer et al., 2011a. Amino acids separation utilized a reverse-phase 
chromatography column (MassTrak AAA 2.1 x 150 mm Column, Waters Corporation, Milford, 
MA). 
 
Doppler ultrasonography 
Carotid arterial hemodynamics were evaluated using duplex B-mode and D-mode 
programs of the color Doppler ultrasound instrument (model SSD-3500; Aloka America, 
Wallingford, CT) with an attached 5.0-MHz finger transducer probe (Aloka UST-672). 
Ultrasound assessments began with a baseline measurement on d 0, continued by d 5, 8, 12, and 
15 of the treatment period. All scans were obtained without use of anesthesia, 10 cm below the 
mandible on the left carotid artery. Prior to scanning the affected area was cleaned and sheared 
of wool; Aquasonic transmission gel (Parker Laboratories, Fairfield, NJ) was utilized as needed. 
Using B-mode, a cross-sectional view of the carotid artery was visualized, and arterial pulsatility 
was confirmed using a duplex view of B-mode and D-mode. This duplex mode also allowed for 
obtaining final hemodynamic measurements by using B-mode for visualization while 
simultaneously using D-mode for recording pulsatile waves. As described in Lemley et al. 
(2012) three comparable cardiac cycle waveforms from three separate ultrasonography 
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assessments were averaged per ewe within a treatment day (9 measurements per day). 
Hemodynamic measurements were calculated using peak systolic velocity (PSV), end-diastolic 
velocity (EDV), mean velocity (MnV), and cross-sectional area of the vessel (CSA). These 
parameters were used to calculate pulsatility index (PI; PI = [PSV (cm/s) – EDV (cm/s)]/MnV 
(cm/s)), an indicator of tissue blood perfusion, and resistance index (RI; RI = [PSV (cm/s) – 
EDV (cm/s)]/PSV (cm/s)), an indicator of vascular resistance. 
 
Statistical analysis 
There were four treatments (n = 15 per treatment) and four sampling periods (after 
baseline hemodynamic measurements). Hemodynamic data were calculated as percent change 
from baseline and then normalized to the control treatment by setting it to zero. No treatment × 
sampling period interactions were present, so main effect least square means are reported (n = 
60). Contrasts were used to address specific questions: CON vs. RP-ARG (CON vs. 90 + 180 + 
360) to test for an overall effect of RP-ARG, linear to test for linear effect of increasing level of 
RP-ARG, and quadratic to test for a quadratic effect of increasing level of RP-ARG. For linear 
and quadratic contrasts unequal spacing coefficients were generated and used for contrast 
statements. For the standard error of the mean (SEM) n = 60. 
Ewe performance data were analyzed as a completely random design using the general 
linear model procedure of SAS (SAS Inst. Inc., Cary, NY) with ewe serving as the experimental 
unit. These contrasts addressed whether overall RP-ARG supplementation had an effect on ewe 
performance (CON vs. 90 + 180 + 360), and whether 180 was the optimal dose of RP-ARG 
supplementation (180 vs. 90, 180 vs. 360). When specific contrast P - values ≤ 0.05 they were 
considered different. 
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Amino acid data were analyzed similar to performance data using contrasts to address 
specific questions. These contrasts addressed whether overall RP-ARG supplementation had an 
effect on circulating serum amino acids (CON vs. 90 + 180 + 360), and whether 180 was the 
optimal dose of RP-ARG supplementation (180 vs. 90, 180 vs. 360). 
 
Results and discussion 
Ewe performance data 
 There were no significant differences in BW either before or after the supplementation 
period (P ≥ 0.12; Table 2.2). This data is similar to Peine et al. (2013) where no difference in 
ewe BW was noted due to arginine supplementation. Ewes receiving 360 mg/kg BW of rumen-
protected arginine were initially more heavily conditioned (greater BCS) than 180 ewes (P = 
0.001), and this difference followed throughout supplementation (P = 0.02). Ewes receiving no 
supplement were initially less conditioned than 360 ewes (P = 0.02), but were statistically not 
different at the end of supplementation (P = 0.08). This small change in condition is probably not 
biologically relevant in this particular study. 
 
    
 
3
0 
Table 2.2. Body weight and BCS measurements in nulliparous ewes fed varying doses of rumen-protected arginine 
 Treatments
1 
  Contrasts
2 
 
Item 
 
0 
 
90 
 
180 
 
360 
 
SEM 
 
P - value 
0 vs. 90, 
180, 360 
180 vs. 
90 
180 vs. 
360 
Initial BW, kg 50.7 47.4 48.7 52.7 1.87 0.22 0.62 0.63 0.14 
Final BW, kg 53.3 49.3 50.3 55.2 1.92 0.12 0.44 0.70 0.08 
  BW change, kg
 
2.7 1.9 1.7 2.6 0.44 0.28 0.21 0.70 0.15 
Initial BCS 2.65
 
2.70
 
2.57
 
2.87
 
0.063 0.01 0.40 0.14 0.001 
Final BCS 2.67
 
2.68
 
2.60
 
2.85 0.072 0.10 0.59 0.42 0.02 
1 
Treatments were administered to ewes daily for 14 d mixed in a 50 g fine ground corn carrier. Treatments were 0, 90, 180, 
and 360 mg of RP-ARG/kg BW daily and are coded 0 (0 mg/RP-ARG/kg BW), 90 (90 mg/RP-ARG/kg BW), 180 (180 
mg/RP-ARG/kg BW), and 360 (360 mg/RP-ARG/kg BW). Control ewes (0) were fed the 50 g of fine ground corn carrier 
without additions of RP-ARG.   
2
There were four treatments (n = 15/treatment). Contrasts were used to address specific questions: 0 (0 mg/RP-ARG/kg BW) 
vs. RP-ARG (CON vs. RP-ARG90 + RP-ARG180 + RP-ARG360) to test for an overall effect of RP-ARG, 180 vs. 90, and 
180 vs. 360 to test for the optimal rumen-protected arginine supplementation dose. For the standard error of the mean 
(SEM), n = 60. 
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Circulating amino acids  
 Baseline levels of circulating serum amino acids (Table 2.3) showed that the only amino 
acids of interest with inherent differences among treatment were glutamate and lysine. Before 
initiating supplementation, circulating levels of glutamate and lysine were greater in 180 ewes 
than in 90 ewes (P = 0.04 and P = 0.02, respectively).  
 Upon completion of the supplementation period, circulating serum levels of arginine 
were greater in 180 vs. 90 ewes (P = 0.05; Table 2.4). This trend was also seen in circulating 
ornithine (P = 0.05) and glutamate (P = 0.02), both of which are downstream of arginine 
metabolism. These results are similar to findings by Southern and Baker (1982), in which dietary 
arginine supplementation increased circulating arginine and ornithine levels. Meyer et al. 
(2011a) also found that increasing doses of rumen-protected arginine supplementation resulted in 
increased serum arginine and ornithine.  
Though there were initial treatment differences in circulating glutamate levels, the 
increase throughout supplementation was greater in 180 ewes than in 360 ewes (P = 0.05; Table 
2.5). Aspartate followed a similar pattern, with a tendency to have greater circulating levels in 
180 vs. 90 ewes at the completion of supplementation (P = 0.08), and a tendency to have a 
greater increase throughout supplementation in 180 vs. 360 ewes (P = 0.07). Both of these AA 
play roles in the urea cycle, therefore these changes may suggest a threshold for urea cycle 
activity induced with supplementation at 180 mg/kg BW. Previous literature has noted increases 
in closely-related glutamine with increasing dose of rumen-protected arginine supplementation, 
but no change in serum glutamate levels (Meyer et al., 2011a). 
 Circulating lysine levels were greater (P = 0.04) in 180 vs. 90 ewes and tended to be 
greater (P = 0.06) in 180 vs. 360 ewes upon completion of supplementation. Throughout 
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supplementation lysine tended to increase in 180 ewes and decrease in 360 ewes (P = 0.06), 
suggesting a possible threshold in doses to induce antagonism in transport. This same 
relationship between doses was reported by Meyer et al. (2011a), in which steers receiving 180 
mg/kg BW rumen-protected arginine had greater serum lysine levels than those receiving 
supplement dosed at 360 mg/kg BW. Similarly, we found circulating levels of histidine increased 
(P = 0.02) in 180 ewes and decreased in 360 ewes throughout supplementation. When comparing 
all arginine supplemented treatments to control, we did not find any evidence for antagonism in 
transport due to arginine supplementation; lysine levels did not change throughout 
supplementation in non-supplemented ewes vs. supplemented ewes (0 vs. 90, 180, and 360; P = 
0.72) and neither did circulating histidine levels (0 vs. 90, 180, and 360; P = 0.58). Southern and 
Baker (1982) found similar data in pigs fed dietary arginine. They noted no change in plasma 
lysine or histidine due to arginine supplementation. This is probably due to the species’ ability to 
synthesize arginine to overcome these effects. 
Based on these amino acid data, it appears that a dose of 180 mg/kg BW is the most 
appropriate dose tested in this study. This is reflected in the increased serum arginine and 
ornithine concentrations at the completion of the supplementation period, along with the 
efficiency in lysine transport that is demonstrated with 180 mg/kg BW dosage, and decreased 
with 360 mg/kg BW dosage. 
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Table 2.3. Baseline serum amino acid levels in nulliparous ewes supplemented varying doses of rumen-protected arginine  
 Baseline AA levels by Treatment,  
µmole per L
1
 
   
Contrasts
2 
  
0 
 
90 
 
180 
 
360 
 
SEM 
 
P - value 
0 vs. 90, 
180, 360 
180 vs. 
90 
180 vs. 
360 
Arginine 164.0
 
173.1
 
180.6
 
175.6
 
5.87 0.25 0.07 0.37 0.55 
Urea Cycle AA
3 
Ornithine 45.3
 
39.4
 
45.0
 
46.5
 
2.12 0.11 0.46 0.07 0.70 
Citrulline 149.9 153.1 143.9 148.1 7.82 0.87 0.86 0.41 0.71 
Aspartate 10.9 10.4 12.1 12.5 0.69 0.13 0.32 0.10 0.65 
Arginine metabolism AA
3 
Ornithine 45.3
 
39.4
 
45.0
 
46.5
 
2.12 0.11 0.46 0.07 0.70 
Citrulline 149.9 153.1 143.9 148.1 7.82 0.87 0.86 0.41 0.71 
Proline 89.0 82.9 91.2 93.9 3.70 0.20 0.94 0.12 0.62 
Glutamate 54.9 44.1 52.2 54.6 2.69 0.02 0.14 0.04 0.53 
Glutamine 472.7 464.2 446.3 486.0 14.33 0.27 0.66 0.38 0.06 
Polyamine AA
3 
Ornithine 45.3
 
39.4
 
45.0
 
46.5
 
2.12 0.11 0.46 0.07 0.70 
Methionine 17.3 17.3 18.5 19.3 0.92 0.33 0.30 0.38 0.52 
Cationic transporter AA
3
  
Lysine 98.2 91.6 115.7 114.7 6.98 0.04 0.26 0.02 0.92 
Ornithine 45.3
 
39.4
 
45.0
 
46.5
 
2.12 0.11 0.46 0.07 0.70 
Histidine 78.9 77.1 77.3 83.3 2.69 0.33 0.91 0.97 0.12 
1 
Treatments were administered to ewes daily for 14 d mixed in a 50 g fine ground corn carrier. Treatments were 0, 90, 180, 
and 360 mg of RP-ARG/kg BW daily and are coded 0 (0 mg/RP-ARG/kg BW), 90 (90 mg/RP-ARG/kg BW), 180 (180 
mg/RP-ARG/kg BW), and 360 (360 mg/RP-ARG/kg BW). Control ewes (0) were fed the 50 g of fine ground corn carrier 
without additions of RP-ARG.   
2
There were four treatments (n = 15/treatment); sampling occurred at d 0 prior to implementation of supplementation. 
Contrasts were used to address specific questions: 0 (0 mg/RP-ARG/kg BW) vs. RP-ARG (CON vs. 90 + 180 + 360) to test 
for an overall effect of RP-ARG, 180 vs. 90, and 180 vs. 360 to test for the optimal rumen-protected arginine 
supplementation dose. For the standard error of the mean (SEM), n = 60. 
3
All amino acids absent already-stated arginine. 
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Table 2.4. Final serum amino acid levels in nulliparous ewes supplemented varying doses of rumen-protected arginine  
 Final AA levels by Treatment,  
µmole per L
1
 
   
Contrasts
2 
  
0 
 
90 
 
180 
 
360 
 
SEM 
 
P - value 
0 vs. 90, 
180, 360 
180 vs. 
90 
180 vs. 
360 
Arginine 160.3
 
158.5
 
178.3
 
176.1
 
7.10 0.11 0.20 0.05 0.83 
Urea Cycle AA
3 
Ornithine 48.8
 
45.5
 
53.2
 
48.6
 
2.69 0.26 0.93 0.05 0.23 
Citrulline 134.5 137.5 138.6 155.0 8.41 0.32 0.35 0.93 0.17 
Aspartate 10.3
 
10.7
 
13.0
 
11.1
 
0.90 0.18 0.23 0.08 0.16 
Arginine metabolism AA
3 
Ornithine 48.8
 
45.5
 
53.2
 
48.6
 
2.69 0.26 0.93 0.05 0.23 
Citrulline 134.5 137.5 138.6 155.0 8.41 0.32 0.35 0.93 0.17 
Proline 95.1 94.3 99.3 91.8 3.48 0.50 0.99 0.31 0.13 
Glutamate 63.7 59.0 75.1 64.5 4.61 0.10 0.64 0.02 0.11 
Glutamine 300.1 295.5 293.8 309.0 8.89 0.63 0.95 0.89 0.23 
Polyamine AA
3 
Ornithine 48.8
 
45.5
 
53.2
 
48.6
 
2.69 0.26 0.93 0.05 0.23 
Methionine 18.1 17.3 19.2 17.6 1.13 0.65 0.94 0.24 0.31 
Cationic transporter AA
3 
Lysine 102.9 100.1 124.1 102.6 7.87 0.12 0.51 0.04 0.06 
Ornithine 48.8
 
45.5
 
53.2
 
48.6
 
2.69 0.26 0.93 0.05 0.23 
Histidine 80.2 78.7 80.7 76.7 2.71 0.72 0.64 0.60 0.30 
1 
Treatments were administered to ewes daily for 14 d mixed in a 50 g fine ground corn carrier. Treatments were 0, 90, 180, 
and 360 mg of RP-ARG/kg BW daily and are coded 0 (0 mg/RP-ARG/kg BW), 90 (90 mg/RP-ARG/kg BW), 180 (180 
mg/RP-ARG/kg BW), and 360 (360 mg/RP-ARG/kg BW). Control ewes (0) were fed the 50 g of fine ground corn carrier 
without additions of RP-ARG.   
2
There were four treatments (n = 15/treatment), sampling occurred at d 15 on the last day of supplementation period. 
Contrasts were used to address specific questions: 0 (0 mg/RP-ARG/kg BW) vs. RP-ARG (CON vs. 90 + 180 + 360) to test 
for an overall effect of RP-ARG, 180 vs. 90, and 180 vs. 360 to test for the optimal rumen-protected arginine 
supplementation dose. For the standard error of the mean (SEM), n = 60. 
3
 All amino acids absent already-stated arginine.
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Table 2.5. Change in serum amino acid levels in nulliparous ewes supplemented varying doses of rumen-protected arginine  
 Change in AA levels by Treatment,  
µmole per L
1 
(Final – Baseline) 
   
 
Contrasts
2 
  
0 
 
90 
 
180 
 
360 
 
SEM 
 
P - value 
0 vs. 90, 
180, 360 
180 vs. 90 180 vs. 
360 
Arginine -3.69 -14.6 -2.4 0.4 6.22 0.35 0.80 0.17 0.75 
Urea Cycle AA
3 
Ornithine 3.5 6.1 8.2 2.4 2.73 0.45 0.51 0.59 0.14 
Citrulline -15.4 -15.5 -5.3 6.9 6.72 0.07 0.17 0.29 0.20 
Aspartate -0.5 0.2 0.9 -1.4 0.87 0.29 0.65 0.60 0.07 
Arginine metabolism AA
3 
Ornithine 3.5 6.1 8.2 2.4 2.73 0.45 0.51 0.59 0.14 
Citrulline -15.4 -15.5 -5.3 6.9 6.72 0.07 0.17 0.29 0.20 
Proline 6.0 11.4 8.1 -2.0 4.58 0.21 0.96 0.61 0.12 
Glutamate 8.7 15.0 22.9 9.9 4.51 0.12 0.17 0.22 0.05 
Glutamine -172.6 -168.7 -152.5 -177.0 13.89 0.62 0.68 0.41 0.22 
Polyamine AA
3 
Ornithine 3.5 6.1 8.2 2.4 2.73 0.45 0.51 0.59 0.14 
Methionine 0.8 0.0 0.7 -1.8 1.14 0.35 0.36 0.65 0.13 
Cationic transporter AA
3 
Lysine 4.7 8.5 8.4 -12.2 7.53 0.18 0.72 0.99 0.06 
Ornithine 3.5 6.1 8.2 2.4 2.73 0.45 0.51 0.59 0.14 
Histidine 1.3 1.6 3.5 -6.6 2.85 0.07 0.58 0.64 0.02 
1 
Treatments were administered to ewes daily for 14 d mixed in a 50 g fine ground corn carrier. Treatments were 0, 90, 180, 
and 360 mg of RP-ARG/kg BW daily and are coded 0 (0 mg/RP-ARG/kg BW), 90 (90 mg/RP-ARG/kg BW), 180 (180 
mg/RP-ARG/kg BW), and 360 (360 mg/RP-ARG/kg BW). Control ewes (0) were fed the 50 g of fine ground corn carrier 
without additions of RP-ARG.   
2
There were four treatments (n = 15/treatment), these data were calculated based on final (d 15) amino acid concentrations – 
baseline (d 0) amino acid concentrations. Contrasts were used to address specific questions: 0 (0 mg/RP-ARG/kg BW) vs. 
RP-ARG (CON vs. 90 + 180 + 360) to test for an overall effect of RP-ARG, 180 vs. 90, and 180 vs. 360 to test for the 
optimal rumen-protected arginine supplementation dose. For the standard error of the mean (SEM), n = 60. 
3
 All amino acids absent already-stated arginine.
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Doppler ultrasound analysis 
All ewes receiving arginine supplement had lower PI, which indicates greater distal tissue 
perfusion, than CON ewes (P = 0.02; Table 2.6). This data was similar to findings by Meyer et 
al. (2011b), in which steers receiving 180 mg/kg BW rumen-protected arginine had lower PI than 
steers receiving no supplement. In the case of this experiment, the tissue of interest for increased 
vascular perfusion is the placenta.  
There was a quadratic effect of supplementation on RI, indicating that ewes receiving 90 
or 180 mg/kg BW of arginine supplement had the least resistance of blood flow in the carotid 
artery (P = 0.01). This was also similar to previous data demonstrating that steers receiving 180 
mg/kg BW rumen-protected arginine had decreased carotid RI as compared to steers receiving 
360 mg/kg BW (Meyer et al., 2011b). 
The mean velocity of blood flow in the carotid artery increased linearly with 
supplementation (P = 0.02). It is interesting that coupled with this, we note a linear decrease in 
CSA due to arginine supplementation (P = 0.001). It is expected that vasodilation effects would 
be the reverse of what was demonstrated. In previous research, both of these parameters were 
unaffected by arginine supplementation (Meyer et al., 2011b).  
In addition, we observed a linear increase in heart rate due to arginine supplementation (P 
= 0.001), coupled with a linear decrease in stroke volume (P = 0.05). These opposing effects 
may explain why we did not observe changes in total cardiac output, as cardiac output is 
determined based on both heart rate and stroke volume. Previous research has noted no change in 
heart rate, stroke volume, or cardiac output due to rumen-protected arginine supplementation in 
steers (Meyer et al., 2011b). 
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This blood flow data also agrees with the amino acid data in that 180 mg/kg BW is the 
most appropriate dose tested for rumen-protected arginine supplementation. This dose 
demonstrated a low RI to permit blood flow with less resistance, and improved distal tissue 
perfusion (lower PI) due to arginine supplementation. Both of these parameters agree with 
previous research in rumen-protected arginine supplementation in steers (Meyer et al., 2011b).  
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Table 2.6. Carotid artery hemodynamics in nulliparous ewes supplemented with varying doses of rumen-protected arginine 
(RP-ARG)
1
   
 Treatments
2 
 Contrast P - values
3
 
Item 0 90 180 360 SEM
 
0 vs.  
90, 180, 
360 Linear Quadratic 
 % change from baseline  
Pulsatililty    
   index 
 
0.00
 
 
-6.99
 
 
-8.30
 
 
-5.10
 
 
2.53 
 
0.02 
 
0.27 
 
0.03 
Resistance  
   index 
 
0.00
 
 
-3.28
 
 
-3.60
 
 
-0.92
 
 
0.93 
 
0.02 
 
0.85 
 
0.01 
Peak systolic 
velocity 
 
0.00 
 
5.49 
 
2.88 
 
10.04 
 
2.99 
 
0.08 
 
0.03 
 
0.89 
End diastolic 
velocity 
 
0.00
 
 
15.84
 
 
13.99
 
 
15.71
 
 
4.80 
 
0.01 
 
0.06 
 
0.11 
Mean velocity 0.00 11.74 10.20 14.53 3.72 0.01 0.02 0.23 
Cross-sectional 
area 
 
0.00 
 
-7.03 
 
-9.99 
 
-11.51 
 
1.82 
 
0.001 
 
0.001 
 
0.03 
Flow volume 0.00 2.75 -4.12 0.74 4.06 0.97 0.91 0.61 
Heart rate 0.00 0.80 3.49 8.92 1.70 0.02 0.001 0.52 
Stroke volume 0.00 3.25 -7.12 -8.88 4.22 0.38 0.05 0.99 
Cardiac output 0.00 1.81 -4.24 -0.12 4.09 0.86 0.83 0.61 
1 
Doppler ultrasonography was performed on nulliparous ewe lambs fed complete pelleted diets and increasing level of rumen-protected 
arginine (RP-ARG). 
2 
Treatments were administered to ewes daily mixed in a 50 g fine ground corn carrier. Treatments were 0, 90, 180, and 360 mg of RP-
ARG/kg BW daily and are coded CON (0 mg/RP-ARG/kg BW), RP-ARG90 (90 mg/RP-ARG/kg BW), RP-ARG180 (180 mg/RP-
ARG/kg BW), and RP-ARG360 (360 mg/RP-ARG/kg BW). Control ewes (CON) were fed the 50 g of fine ground corn carrier without 
additions of RP-ARG.   
3
There were four treatments (n = 15/treatment) and four sampling periods (after baseline hemodynamic measurements). Data were 
calculated as percent change from baseline and then normalized to the control treatment by setting it to zero. No treatment × sampling 
period interactions were present, so main effect least square means are reported (n = 60).
 
Contrasts were used to address specific 
questions and were CON vs. RP-ARG (CON vs. RP-ARG90 + RP-ARG180 + RP-ARG360) to test for an overall effect of RP-ARG, 
Linear to test for a linear effect of increasing level of RP-ARG, and quadratic to test for a quadratic effect of increasing level of 
arginine.  For linear and quadratic contrasts unequal spacing coefficients were generated and used for contrast statements. For the 
standard error of the mean (SEM) n = 60. 
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CHAPTER 3. EFFECTS OF MATERNAL NUTRITION AND RUMEN-
PROTECTED ARGININE SUPPLEMENTATION ON EWE AND POSTNATAL 
LAMB PERFORMANCE 
 
 
Abstract 
Our hypothesis was that arginine supplementation would overcome the negative effects 
of restricted maternal intake during the last two-thirds of gestation on ewe and lamb 
performance. To test this hypothesis, multiparous, Rambouillet ewes (n = 32) were allocated to 3 
treatments in a completely random design at 54 ± 3.9 d of gestation. Dietary treatments were 
100% of requirements (control, CON), 60% of control (restricted, RES), or RES plus a rumen-
protected arginine supplement dosed at 180 mg/kg BW once daily (RES-ARG). Ewes were 
penned individually in a temperature-controlled facility. At parturition, lambs were immediately 
removed from their dam and reared independently. At d 54 ± 3 of age, lambs were stunned using 
captive bolt and exsanguinated, and organs were collected and weighed. Ewe BW from d 75 of 
gestation through parturition was greater (P ≤ 0.05) in CON compared with RES or RES-ARG.  
Similarly, ewe BCS from d 82 of gestation through parturition was greater (P ≤ 0.02) in CON 
than either RES or RES-ARG. Total ewe colostrum mass (g) at 3 h after parturition was greater 
(P ≤ 0.001) in CON than RES or RES-ARG. Lamb birth weight was greater (P = 0.04) in CON 
than RES ewes, and tended (P = 0.10) to be greater in CON vs. RES-ARG. Lambs born to CON 
ewes had greater (P ≤ 0.03) BW than lambs from RES ewes at 7, 14, and 33 d postpartum. On d 
19, lambs from CON and RES-ARG ewes both had greater (P ≤ 0.04) BW than lambs from RES 
ewes (12.0 and 11.5 vs. 10.3 ± 0.41 kg, respectively). Lambs born to CON and RES-ARG ewes 
had greater (P ≤ 0.04) average daily gain (ADG) than lambs from RES ewes on d 19 (355.0 and 
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354.0 vs. 306.4 ± 15.77 g, respectively). Lambs from CON and RES-ARG ewes also had greater 
(P ≤ 0.02) girth circumference than lambs from RES ewes on d 19 (55.4 and 54.6 vs. 51.3 ± 0.97 
cm, respectively). On d 54, lambs from RES-ARG ewes had greater (P = 0.003) curved crown 
rump length than lambs from RES ewes (99.8 vs. 93.9 ± 1.28 cm, respectively). Adrenal glands 
in lambs from CON dams had greater (P = 0.04) mass than adrenal glands in lambs from 
restricted dams (RES + RES-ARG). Livers in lambs from RES-ARG ewes weighed more (P = 
0.05) than lambs from RES ewes. These results confirm our hypothesis that arginine 
supplementation during the last two-thirds of gestation can mitigate some negative consequences 
associated with restricted maternal nutrition in the offspring, but not in the underfed dams 
themselves. 
 
Introduction 
Fetal growth restriction (FGR) has been implicated as the cause of many deleterious 
postnatal offspring performance defects or traits, including lower birth weights and poor neonatal 
growth and body composition (Wu et al., 2006; Caton and Hess, 2010; Reynolds and Caton, 
2012). One of the major causes of FGR is compromised maternal nutrition, which may occur in 
extensive grazing systems. In the Western U.S., grazing ewes often receive less than 50% of 
NRC recommendations, resulting in loss of body weight during pregnancy and reduced lactation 
performance (Wu et al., 2006; Meyer et al., 2011; Long et al., 2009).   
A potential supplement to offset FGR is arginine, a semi-essential amino acid. Arginine 
contributes to NO and polyamine production, both of which play key roles in placental growth 
and function (Martin et al., 2001; Kwon et al., 2003; Wu et al., 2009). Nitric oxide and 
polyamines play unique roles in regulating fetal development throughout gestation, and 
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contribute to nutrient delivery to, and use by, the developing fetus despite maternal 
undernutrition. Improved fetal growth has been demonstrated in ovine models of FGR in 
response to intravenous arginine administration (Wu et al., 2009). Arginine may also enhance 
offspring growth via insulin stimulation or other avenues of glucose metabolism (Floyd et al., 
1966; Schmidt et al., 1992; Gannon et al., 2002). Lassala et. al. (2010) found that arginine 
administration to underfed ewes enhanced offspring birth weights by 21% as compared to saline-
infused underfed ewes; birth weights of offspring from arginine-infused underfed ewes were 
equal to those from control-fed ewes.  
Use of current rumen protection technologies allows for oral administration of specific 
amino acids with subsequent delivery to the small intestine, which is a practical approach for 
strategic supplement delivery to ruminants. In this study, we tested the hypothesis that arginine 
supplementation would mitigate the negative effects of compromised maternal nutrition during 
the last two thirds of gestation on both ewe and lamb performance. We expected lambs from 
nutrient restricted, arginine supplemented dams to present as normal and therefore be similar to 
lambs from control-fed ewes.   
 
Materials and methods 
Animals   
Protocols described herein were approved by the North Dakota State University 
Institutional Animal Care and Use Committee. Multiparous Rambouillet-cross ewes (n = 32; 
67.7 ± 6.2 kg initial BW) were confirmed pregnant via ultrasound on 41 ± 6.0 d after mating. 
Ewes were housed individually in a climate controlled facility with free access to water.  Ewes 
were fed a pelleted diet daily at 0800. Weekly ewe BW measurements allowed monitoring of 
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ewe BW change to determine if dietary adjustments were needed. Body condition scores were 
assessed every two weeks by two or three independent observers. 
 
Experimental design and treatments  
This experiment was a completely randomized design. Ewes were randomly assigned to 
one of three treatments at 54 ± 3.9 d of gestation: 100% of dietary requirements (control, CON; 
based on NRC, 1985, 2007), 60% of control (restricted, RES), or RES with the addition of a 
rumen-protected arginine (RP-ARG, Kemin Industries, Des Moines, IA) supplement (RES-
ARG). Supplement provided to the RES-ARG ewes contained 180 mg arginine/kg BW (based 
on initial BW). Arginine was mixed with 50 g of fine ground corn and fed once daily at 0800 
before offering the pelleted diet. Both CON and RES ewes were also provided 50 g of fine 
ground corn daily, without the added rumen protected arginine. Pelleted diets (Table 2.1 from 
Chapter 2, same diet as the previous study) were fed once daily to ewes on an individual basis, 
with amounts specific to ewe BW and targeted nutrient supply. Pelleted diets were consumed 
within 2 h of feeding. Treatments continued until parturition. Two CON and one RES ewe died 
(2 unknown causes and 1 pneumonia) before parturition. Their data were included in the 
analyses up to removal from the study.  
 
Parturition and lamb management 
A closely monitored, 24 h lambing protocol was implemented during the expected dates 
of parturition. At parturition, lambs were not permitted to suckle from ewes, and were removed 
from dams immediately and reared independently. There were four sets of twins (2 CON, 1 RES, 
and 1 RES-ARG). At 3 h post parturition, ewes were administered a 1 mL (20 USP units) 
 45 
 
intramuscular injection of Oxytocin (Vet Tek, Blue Springs, MO) and milked out to determine 
colostrum weight.   
Following removal from the ewe, lambs were towel dried and weighed. Lambs received 
an intramuscular injection of vitamin A, D, and E (0.5 mL/lamb; 100,000 IU of A, 10,000 IU of 
D3, 300 IU of E/mL; Stuart Products, Bedford, TX), and 1 mL of Clostridium perfringens types 
C and D and tetanus vaccine (Essential 3+T, Colorado Serum, Denver, CO) subcutaneously. 
Finally, the umbilical cord was clipped and dipped in 7% iodine tincture. 
Lambs received artificial colostrum (Lifeline Rescue Colostrum, APC, Ankeny, IA), 
administered at 19.1 mL/kg of lamb birth weight at 0 and 2 h post birth, and 25.5 mL/kg of lamb 
birth weight at 4, 8, 12, 16, and 20 h post birth to achieve 10.64 g IgG/kg lamb birth weight, as 
previously described (Meyer et al., 2010; Neville et al., 2010).   
Lambs were group housed in a climate controlled facility with free access to water. At 24 
h post birth, lambs received milk replacer (Super Lamb Milk Replacer, Merrick’s Inc., 
Middleton, WI; DM basis: 24% CP, 30% fat, 0.10% crude fiber, 0.5 to 1.0% Ca, 0.65% P, 0.3 
ppm Se, 66,000 IU/kg vitamin A, 22,000 IU/kg vitamin D, and 330 IU/kg vitamin E) for ad 
libitum intake via bottle until a strong suckling response was observed. Lambs then transitioned 
to a teat bucket system (Meyer et al., 2010; Neville et al., 2010). In addition to milk replacer, a 
mixture of long stem mid-bloom alfalfa hay and creep feed (DM basis: 20% CP, 6% fat, 8% 
crude fiber, 1.4 to 1.9% Ca, 0.4% P, 0.5% to 1.5% NaCl, 0.3 ppm Se, 11,000 IU/kg vitamin A, 
6,000 IU/kg vitamin D, and 100 IU/kg vitamin E) were available ad libitum. At 7 d, all tails were 
docked and male lambs were castrated by banding. At 40 ± 3 d, lambs received an additional 2-
mL injection of vitamin A, D, and E as previously described. Lamb BW was measured at birth, 
24 h, and 3, 7, and 14, 19, 33, 40, 47, and 54 ± 3 d. Curved crown rump length, measured as the 
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distance from the crown of the head to the rump along the backbone, and girth, measured as the 
circumference around the rib cage just behind the forelegs, were determined at birth, and at 19 
and 54 d. Two lambs died during the experiment of unrelated causes, one at 7 d (RES-ARG), and 
another at 45 d (RES). Their data were included in the analyses up to removal from the study.   
 
Necropsy 
At d 54 ± 3 of age, lambs were stunned using captive bolt and exsanguinated. Viscera 
were removed and dissected, and the liver and pancreas were separated from the viscera to obtain 
individual organ weights. The digestive tract was stripped of digesta and fat, and the ileum, 
duodenum, and jejunum were separated from the large intestine as described by Soto-Navarro et 
al. (2004), and each component weighed. The heart was also removed and measured for ventricle 
dimensions and thickness. In addition, the brain, adrenal glands, kidneys, gonads, spleen, 
stomach complex, and thyroid were removed and each component weighed. 
 
Jejunal histological analyses 
 Jejunal tissue was further dissected to a 15 cm segment for mucosal analysis; the segment 
was cut open flat along the mesenteric side and the luminal surface washed with PBS. After 
rinsing, the mucosa was scraped from the section using a glass microscope slide. Differential 
weights were taken on the segment before and after mucosal removal to determine percent 
mucosa in the jejunum. 
 Further dissection of jejunal tissue yielded sections (< 1 cm wide) for immersion-fixation 
in neutral buffered formalin (NBF), and tissues were ultimately stored in 70% ethanol solution. 
Following fixation, these tissue sections were embedded in paraffin (Reynolds and Redmer, 
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1992) and cut to 5-µm cross-sections. These 5-µm cross-sections were mounted on glass slides, 
deparaffinized in Histoclear (Electron Microscopy Services, Hatfield, PA), and rehydrated 
through a series of ethanol/water solutions. Antigen retrieval was performed for 15 minutes with 
a 10 mM sodium citrate 0.05% tween (pH = 6) buffer in a 2100 retriever (Electron Microscopy 
Sciences, Hatfield, PA); following antigen retrieval slides were cooled to room temperature for 
20 minutes. Tissues were rinsed twice with tris buffered saline (TBS) containing 0.1% Triton X-
100 (TBST) prior to treatment with a blocking buffer consisting of TBS and 10% normal goat 
serum (Vector Laboratories, Burlingame, CA) for 20 minutes. Primary antibody against Ki67 
(1:100; Clone MM1; Vector Laboratories, CA) was used to treat slides overnight at 4°C to mark 
those cells that are proliferating (Freetly et al., 2014). The following day, slides were washed in 
TBST prior to treatment in total darkness using a goat anti-mouse CF633 secondary antibody 
(1:200; 89138-632; VWR, Radnor, PA) for 30 minutes. Finally, slides were washed in distilled 
water prior to coverslip application using Vectashield Hardset mounting medium (Vector 
Laboratories, Inc., Burlingame, CA) containing 4’,6-diamidino-2-phenylindole (DAPI).  
 Slides were visualized via photomicrographs taken on Zeiss Imager.M2 epifluorescence 
microscope using 10x objective and AxioCam HRm camera with a Zeiss piezo automated stage. 
Photomicrographs were taken at six random locations per animal visualizing the crypt region of 
the intestine, as this is the primary location of intestinal cell proliferation. Images were analyzed 
using Image-ProPlus 5.0 software (MediaCybernetics Inc., Silver Spring, MD) for percentage of 
proliferating Ki-67–positive cells of the total number of cells within the analyzed crypt region. 
Of the six photomicrographs, the three proliferation percentage calculations within the smallest 
range of each other were used to calculate an average percent proliferation for each lamb. 
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Statistical analysis 
Data were analyzed as a completely random design using the GLM procedure of SAS 
(SAS Inst. Inc., Cary, NY) with ewe or lamb serving as the experimental unit. Fetal number was 
included in the model statement and retained if significant (P ≤ 0.10). After protection with an 
overall F-test for treatment (P ≤ 0.10) means were separated using the PDIFF procedure of SAS 
and P - values ≤ 0.05 were considered different.   
 
Results and discussion 
Ewe performance  
Restricted (RES and RES-ARG) ewes weighed less (P ≤ 0.05) than CON ewes from d 75 
of pregnancy until parturition (Table 3.1). Similarly, RES and RES-ARG ewes had lower (P ≤ 
0.02) BCS than CON ewes from d 82 throughout parturition, and by d 68 CON ewes had greater 
(P ≤ 0.03) BCS than RES-ARG ewes (Table 3.2). These results are similar to those reported by 
Meyer et al. (2010). Changes in ewe BW and BCS in CON and RES ewes indicate our 
experimental model responded as predicted and was appropriate for testing our hypothesis 
regarding supplementation of rumen-protected arginine. In this study, the arginine treatment had 
no rescue effect (P ≥ 0.82) on ewe BW or BCS. Similar maternal performance based on arginine 
supplementation was observed by Satterfield et al. (2013). 
Colostrum produced at 3 h postpartum by CON ewes was greater (P ≤ 0.001) compared 
with RES and RES-ARG ewes (753.7 vs. 298.6 and 105.4 ± 88.31 g, respectively). Differences 
observed between CON and RES were expected and reported previously (Wu et al., 2006; 
Swanson et al., 2008; Meyer et al., 2011). Results also indicated that rumen-protected arginine 
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supplementation did not rescue colostrum yield in restricted ewes. Effects of the arginine 
supplement used in this study on longer-term lactation responses were not determined. 
 
Table 3.1. Influence of nutrient restriction and arginine supplementation on ewe BW (kg) 
throughout gestation 
 Treatment
1 
  
d CON RES RES-ARG SEM P - value 
54 63.8 63.7 64.2 1.95 0.98 
61 64.1 60.3 60.9 1.95 0.32 
68 62.9 57.8 57.5 1.94 0.09 
75 62.3
b 
56.8
a 
56.7
a 
2.00 0.07 
82 64.1
b 
57.9
a 
57.3
a 
1.99 0.03 
89 65.3
b 
58.1
a 
57.6
a 
2.09 0.02 
96 65.5
b 
57.9
a 
57.9
a 
2.20 0.02 
103 65.7
b 
57.7
a 
57.4
a 
2.13 0.01 
110 66.4
b 
57.7
a 
57.7
a 
2.06 0.005 
117 67.0
b 
56.9
a 
56.5
a 
2.16 0.002 
124 67.6
b 
56.3
a 
56.7
a 
2.17 0.001 
131 67.9
b 
56.0
a 
56.3
a 
2.13 <0.001 
138 69.6
b 
56.6
a 
56.9
a 
2.12 <0.001 
145 69.6
b 
56.3
a 
56.1
a 
2.23 <0.001 
152 67.0
b 
56.5
a 
56.6
a 
3.30 0.06 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 
11); RES-ARG = restricted + arginine, 60% CON nutrients with rumen-protected arginine 
supplement (n = 10). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
 
Table 3.2. Influence of nutrient restriction and arginine supplementation on ewe BCS 
throughout gestation
1 
 Treatment
2 
  
d CON RES RES-ARG SEM P - value 
54 2.90 2.91 2.88 0.075 0.94 
68 2.94
b 
2.78
ab 
2.71
a 
0.073 0.08 
82 2.99
b 
2.65
a 
2.66
a 
0.094 0.02 
96 2.90
b 
2.47
a 
2.42
a 
0.093 0.001 
110 2.93
b 
2.40
a 
2.34
a 
0.137 0.006 
124 2.98
b 
2.26
a 
2.26
a 
0.108 <0.001 
138 2.90
b 
2.01
a 
2.05
a 
0.133 <0.001 
152 2.75
b 
1.65
a 
1.79
a 
0.199 0.001 
1
BCS structured by scale of 1 = thin to 5 = over conditioned 
2
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 
11); RES-ARG = restricted + arginine, 60% CON nutrients with rumen-protected arginine 
supplement (n = 10).
 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
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Lamb birth weight and performance 
Lambs from CON ewes had greater (P = 0.04) BW at birth than lambs from RES ewes, 
with lambs from RES-ARG fed ewes being intermediate and similar to both CON and RES 
(Table 3.3). This same response was observed for lamb BW on d 7, 14, and 33. On d 3, lambs 
from CON ewes weighed more (P ≤ 0.02) than lambs from RES and RES-ARG ewes. On d 19, 
lambs from CON and RES-ARG ewes weighed more (P ≤ 0.04) than lambs from RES ewes. 
Keeping with our hypothesis, these data indicate that arginine may play a role in recovering 
postnatal BW in lambs from nutritionally compromised dams. This hypothesis is further 
supported in data by Lassala et al. (2010), where lambs from ewes on a restricted nutrient plane 
receiving IV L-arginine were similar in birth weights to lambs from adequately fed ewes, both 
with heavier birth weights than lambs from ewes on nutrient restriction (50% NRC 
requirements). 
 
Table 3.3. Influence of maternal nutrient restriction and arginine supplementation on offspring 
BW (g) over time 
 Maternal Treatment
1 
  
d CON RES RES-ARG SEM P - value 
0 5,228
b 
4,449
a 
4,603
ab 
257.1 0.09 
3 6,045
b 
4,692
a 
4,990
a 
298.2 0.008 
7 7,112
b 
6,100
a 
6,321
ab 
312.7 0.07 
14 9,882
b 
8,811
a 
9,459
ab 
308.8 0.05 
19 11,973
b 
10,272
a 
11,500
b 
405.3 0.01 
33 17,360
b 
15,278
a 
16,202
ab 
574.5 0.04 
40 19,971 18,072 19,488 705.7 0.14 
47 21,765 20,606 22,028 796.9 0.41 
54 23,830 21,870 23,656 889.9 0.24 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 
11); RES-ARG = restricted + arginine, 60% CON nutrients with rumen-protected arginine 
supplement (n = 11). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
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Lamb ADG followed a similar pattern as BW, with lambs from CON and RES-ARG 
ewes having greater (P ≤ 0.04) ADG than lambs from RES ewes on d 19 (Table 3.4). Girth 
measurements at birth and d 54 were greater (P = 0.03) in lambs from CON compared with RES 
ewes, with RES-ARG being intermediate and similar to both CON and RES (Table 3.5). 
However, on d 19 lambs from CON and RES-ARG ewes had greater (P ≤ 0.02) girth 
measurements than lambs from RES ewes. Lambs from RES-ARG ewes had greater (P = 0.003) 
curved crown rump measurements than lambs from RES ewes on d 54, with lambs from CON 
ewes being intermediate and similar to both RES and RES-ARG. These data support the 
potential role arginine may play in enhancing offspring growth from underfed dams. 
 
Table 3.4. Influence of maternal nutrient restriction and arginine supplementation on offspring 
ADG (g) over time 
 Maternal Treatment
1 
  
d
2 
CON RES RES-ARG SEM P - value 
3 272.4 81.0 129.1 72.96 0.17 
7 269.1 235.9 245.4 19.49 0.47 
14 332.4 311.5 334.7 13.14 0.37 
19 355.0
b 
306.4
a 
354.0
b 
15.77 0.05 
33 367.6
 
328.1
 
346.3
 
13.29 0.11 
40 368.6 340.6 367.9 14.45 0.28 
47 351.9 342.3 367.1 15.02 0.51 
54 344.5 321.4 349.7 14.98 0.37 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 
11); RES-ARG = restricted + arginine, 60% CON nutrients with rumen-protected arginine 
supplement (n = 11). 
2
Interval of d for ADG measured between two subsequent dates (i.e. d 3 through 7 = d 7 ADG) 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
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Table 3.5. Influence of maternal nutrient restriction and arginine supplementation on offspring 
girth (cm) and curved crown rump (cm) length over time 
 Maternal Treatment
1 
  
Item CON RES RES-ARG SEM P - value 
Girth       
   0d 42.2
b 
38.6
a 
39.4
ab 
1.14 0.08 
   19d 55.4
b 
51.3
a 
54.6
b 
0.97 0.01 
   54d 70.8
b 
67.0
a 
69.7
ab 
1.23 0.10 
CCR       
   0d 54.9 52.6 55.1 1.49 0.43 
   19d 73.7 69.4 72.9 1.86 0.21 
   54d 96.3
ab 
93.9
a 
99.8
b 
1.28 0.01 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 
11); RES-ARG = restricted + arginine, 60% CON nutrients with rumen-protected arginine 
supplement (n = 11). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
 
Lamb organ mass 
 After organ collection and weighing, no differences (P ≥ 0.44) were observed based on 
nutritional plane or arginine supplementation in total GI tract weight (Table 3.6). These results 
contradict Meyer et al. (2013), where lambs from adequately-fed ewes had greater empty GI tract 
weights than lambs from nutrient-restricted ewes. These measurements were taken in lambs 19 to 
22 d of age, which are significantly younger than in the present study. It is possible that these 
differences may have been present during fetal development and at birth, but corrected during 
growth. To support this, Reed et al. (2007) observed several differences in organ mass of 
offspring from restricted ewes compared to offspring from control-fed ewes when offspring were 
harvested just before birth at d 135 ± 5 d of gestation. These differences may have disappeared if 
offspring were followed to a later age. 
 Adrenal glands in lambs from CON dams had greater (P = 0.01) mass than adrenal glands 
in lambs from RES dams, and tended to have greater (P = 0.07) mass than lambs from RES-
ARG dams. Also, pancreases in lambs from CON ewes were greater (P = 0.04) in mass than 
lambs from RES ewes. These organs are major users of glucose: the pancreas uses glucose for 
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insulin and the adrenal glands as synthesis of glucocorticoids. This suggests a possible difference 
in our offspring in circulating glucose, which has been documented to be lower in bovine FGR 
offspring in previous literature (Long et al., 2009). In offspring of smaller size like our RES 
offspring, there will be less maintenance costs for glucose to feed, so smaller adrenal glands and 
pancreas are adequate for their health and maintenance. In addition, the pancreas also houses 
proteolytic enzymes which RES offspring may use less of due to slower or lesser metabolism of 
protein. 
 Livers in lambs from RES-ARG ewes weighed more (P = 0.05) than lambs from RES 
ewes. This is intriguing, as the liver is the primary organ for ureagenesis, a process that arginine 
is essential for. Ureagenesis is especially important in ruminants, as urea synthesized in the liver 
can be released for urea recycling to the digestive tract to meet protein needs of the animal. This 
could be an essential process in a nutrient-restricted gestational environment, when the animal is 
most likely not receiving enough dietary protein to meet requirements. The crucial role of 
maternal protein in fetal development has been well documented (Wu et al, 2006; Larson et al., 
2009). A smaller liver for RES offspring may be sufficient for the amount of arginine they have 
to contribute to the urea cycle, whereas a RES-ARG lamb may have more arginine to contribute, 
and therefore would perform the urea cycle more readily. This in turn could allow them to 
recycle more urea to meet protein requirements more efficiently.  
 
Jejunal characteristics 
 Further analysis of the jejunum showed that on a g/kg BW basis, offspring from CON 
ewes tended (P = 0.06) to have greater jejunal mass than offspring from RES ewes. This may 
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contribute to the difference in gain between maternal nutritional treatments, as the jejunum is the 
major location of the small intestine for nutrient absorption. 
There were no differences in total jejunum weight, percent mucosa, mucosal tissue 
weight, or percent cell proliferation in the jejunum (P ≥ 0.28). This is inconsistent with 
Yunusova et al. (2013), in which offspring from nutrient restricted and overfed ewes were 
compared to those from control-fed ewes in terms of small intestinal biology. Offspring from 
both nutrient restricted and overfed ewes had decreased (P = 0.09) crypt cell proliferation 
compared to offspring from control-fed ewes.  However, tissues were harvested from these 
offspring at 180 d. It is possible that if we had followed our offspring to a later age we may have 
seen this effect develop. This may also contribute to offspring with fewer differences in organ 
weights among treatments as age progresses. The intestine of offspring from restricted ewes may 
adapt to expend less energy on crypt cell regeneration in order to allow organ development to 
progress. 
 
 
 
 
 
 
 
 
 
 
  
 
5
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Table 3.6. Influence of maternal nutrient restriction and arginine supplementation on offspring organ mass at d 54 of age 
 Maternal Treatments 
Organ CON RES RES-ARG SEM P - value 
Brain, g 
     g/kg BW 
93.6 
4.05 
93.4 
4.31 
92.7 
3.96 
2.69 
0.224 
0.97 
0.52 
Adrenals, g 
     g/kg BW 
1.72
a 
0.074 
1.46
b 
0.067 
1.54
ab 
0.065 
0.072 
0.0035 
0.03 
0.18 
Thyroid, g 
     g/kg BW 
1.80 
0.076 
1.81 
0.083 
1.93 
0.082 
0.139 
0.0056 
0.77 
0.61 
Heart, g 
     g/kg BW 
147.0 
6.19
 
132.3 
6.08
 
138.4 
5.87
 
5.38 
0.169 
0.16 
0.40 
Liver, g 
     g/kg BW 
481.2 
20.34
 
429.5 
19.63
 
490.0 
20.70
 
21.08 
0.616 
0.11 
0.47 
Pancreas, g 
     g/kg BW 
28.7 
1.20 
24.3 
1.10 
27.2 
1.16 
1.53 
0.058 
0.12 
0.47 
Kidneys, g 
     g/kg BW 
106.1 
4.46 
102.6 
4.68 
108.6 
4.58 
4.67 
0.084 
0.66 
0.17 
Total visceral  
adiposity, g 
  g/kg BW 
  Omental fat, g 
     g/kg BW 
  Perirenal fat, g 
     g/kg BW 
 
1,021.7 
41.5 
511.6 
20.69 
510.0 
20.79 
 
851.2 
38.9 
424.4 
19.38 
426.8 
19.52 
 
888.1 
37.5 
487.8 
20.55 
400.3 
16.97 
 
102.40 
3.83 
53.87 
2.013 
55.98 
2.182 
 
0.45 
0.75 
0.49 
0.88 
0.34 
0.45 
Full GI tract, g 
     g/kg BW 
3,732.2 
156.4 
3,330.8 
152.5 
3,471.6 
147.2 
186.73 
5.82 
0.30 
0.52 
Empty GI tract, g 
     g/kg BW 
955.9 
40.59 
891.2 
40.91 
920.2 
39.00 
35.35 
1.172 
0.44 
0.48 
Stomach, g 
     g/kg BW 
304.5 
12.78 
267.8 
12.31 
259.0 
11.10 
15.67 
0.630 
0.10 
0.16 
Small intestine, g 
     g/kg BW 
454.7 
19.37 
442.8 
20.31 
470.5 
19.85 
20.55 
0.707 
0.64 
0.65 
Large intestine, g 
     g/kg BW 
190.4 
8.09 
180.6 
8.28 
190.7 
8.05 
9.74 
0.394 
0.71 
0.91 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 11); RES-ARG = restricted + 
arginine, 60% CON nutrients with rumen-protected arginine supplement (n = 11). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
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Table 3.7. Influence of maternal nutrient restriction and arginine supplementation on offspring small intestine characteristics 
at d 54 of age 
 Maternal treatments   
Item CON RES RES-ARG SEM P - value 
Small intestine, g 
     g/kg BW 
     Duodenum, g 
          g/kg BW 
     Ileum, g 
          g/kg BW 
     Jejunum, g 
          g/kg BW 
454.7 
19.37 
43.9 
1.84 
263.5 
11.07 
63.9 
2.72 
442.8 
20.31 
41.2 
1.88 
207.6 
9.53 
95.8 
4.46 
470.5 
19.85 
43.5 
1.85 
256.9 
10.70 
78.0 
3.39 
20.55 
0.707 
7.88 
0.316 
21.98 
0.782 
14.09 
0.629 
0.64 
0.65 
0.97 
1.00 
0.16 
0.35 
0.29 
0.16 
Jejunal Characteristics  
Jejunum, g 
  g/kg BW 
63.9 
2.72 
95.8 
4.46 
78.0 
3.39 
14.09 
0.629 
0.29 
0.16 
% mucosa 81.5% 82.0% 84.3% 1.43 0.34 
Mucosal weight  52.0 79.6 65.9 11.95 0.28 
Percent cell    
  proliferation 
 
29.9 
 
36.8 
 
           30.2 
 
4.100 
 
0.41 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 11); RES-ARG = restricted + 
arginine, 60% CON nutrients with rumen-protected arginine supplement (n = 11). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
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Conclusions 
Ewe performance outcomes were inconsistent with our hypothesis and were not 
responsive to supplemental rumen-protected arginine during gestation. However, in keeping with 
our hypothesis, lamb BW, ADG, and body size measurements were responsive while organ 
masses were not responsive to maternal rumen-protected arginine supplementation. Additional 
research is needed to further define the effects of supplementation of rumen-protected arginine 
during gestation on offspring heath and performance outcomes. 
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CHAPTER 4. EFFECTS OF MATERNAL NUTRITION AND RUMEN-PROTECTED 
ARGININE SUPPLEMENTATION ON MATERNAL CAROTID ARTERIAL 
HEMODYNAMICS AND CIRCULATING AMINO ACIDS IN DAMS AND OFFSPRING 
 
Abstract 
Our hypothesis was that rumen-protected arginine supplementation during gestation 
would induce improved gestational hemodynamics in ewes by increasing distal tissue perfusion 
while decreasing vascular resistance. We further hypothesized that maternal supplementation of 
this amino acid would affect circulating concentrations of related amino acids: citrulline, 
ornithine, lysine, and histidine, in both dams and their offspring. To test our hypothesis, we 
randomly assigned (n = 32) multiparous Rambouillet ewes to one of three treatments: control 
(CON) received 100% nutrient requirements during gestation, restricted (RES) received 60% 
nutrient requirements during gestation, and a third group received the RES diet with 180 mg/kg 
daily rumen-protected arginine supplement (RES-ARG). Ewes were penned individually in a 
temperature-controlled facility.  Hemodynamics were measured via Doppler ultrasound with 
baseline measurements at d 50, followed by scans on d 90 and 130 of gestation. We observed no 
change in hemodynamics during gestation based on arginine supplementation; however, CON 
ewes did have increased (P = 0.05) distal tissue perfusion compared to both groups of restricted 
ewes (RES and RES-ARG). Blood samples were taken from ewes on d 54, 82, 110, and 138 of 
gestation, along with immediately post parturition. We observed that throughout gestation RES-
ARG ewes had significantly more circulating citrulline than RES ewes (P = 0.002). At 
parturition, CON and RES-ARG ewes had similar (P = 0.29), while RES ewes had lower 
circulating citrulline concentrations (P ≤ 0.03). We did not see overall gestation differences (P = 
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0.17) in circulating arginine concentrations among treatments in ewes. At parturition, lambs were 
immediately removed from their dam and reared independently. Blood samples were taken from 
lambs on d 1, 3, 7, 33, and 54 of age. At 24 h (d 1) of age, lambs from CON dams had greater (P 
= 0.008) circulating arginine concentrations than lambs from RES dams, with lambs from RES-
ARG dams intermediate to both (P ≥ 0.09). By d 54 of age, lambs from RES-ARG dams had 
greater (P = 0.02) circulating arginine concentrations than CON, while RES was intermediate to 
both (P ≥ 0.19). These results do not follow our hypothesis that arginine supplementation will 
improve hemodynamics during gestation, but do confirm that maternal rumen-protected arginine 
supplementation will alter maternal arginine and related amino acid concentrations during 
gestation and in their offspring. 
 
Introduction 
 Numerous arginine supplementation strategies have been studied for their effectiveness in 
delivering arginine to the bloodstream; however, in ruminants, this presents a more unique 
challenge. Dietary supplementation of amino acids to ruminants is, as a standard, not effective 
due to the ability of the rumen to break down the amino acids before they can reach the small 
intestine for absorption. Rumen protection technologies have made amino acid supplementation 
to ruminants possible (Oke et al., 1986). With proper protection technology, a dietary amino acid 
supplement should be able to pass through the rumen intact and be absorbed into the bloodstream 
via the small intestine. Several rumen-protected amino acid supplements are available and in use, 
especially methionine and lysine (Oke et al., 1986; Sun et al., 2007; Schwab and Ordway); 
however, rumen-protected arginine is not currently commercially available. 
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 Arginine has been an amino acid of interest for supplementation primarily due to its 
effects on blood flow. Arginine provides the N to synthesize NO from NOS enzymes (Morris et 
al., 2007; Wu et al., 2009; Wu et al., 2013). Nitric oxide is a vasodilator that will increase blood 
flow by affecting vascular tone (Martin et al., 2001). Meyer et al. (2011b) found that rumen-
protected arginine supplementation to steers can influence carotid arterial hemodynamics by 
increasing distal tissue perfusion and decreasing resistance in the vessel. These blood flow 
effects are especially of interest during gestation, as increased blood flow to the placenta may 
increase nutrient transport to the developing fetus. It has been demonstrated that at-risk 
pregnancies are often associated with impaired blood flow during gestation; however, previous 
studies have demonstrated that therapeutics targeting the NO system may be effective in 
increasing blood flow to help to rescue the pregnancy (Reynolds et al., 2006).  
A common cause of at risk pregnancies is FGR in utero, which can be induced by poor 
maternal nutrition during gestation (Wu et al., 2006). Lassala et al. (2010) administered arginine 
infusions via jugular catheter to gestating ewes receiving 50% of their daily nutrient 
requirements, and saline infusions to half of the underfed ewes along with ewes receiving 100% 
of their daily nutrient requirements from d 60 of gestation through parturition. This arginine 
infusion to underfed ewes enhanced birth weights by 21% as compared to underfed ewes 
receiving saline. Lambs from arginine-infused underfed dams were not different than lambs from 
control-fed saline-injected ewes. Their study demonstrates that arginine administration during 
gestation to at-risk pregnant dams may rescue the fetus from deleterious life effects. 
It is prudent to note that administration of any amino acid will effect metabolism of other 
amino acids – some positively and some negatively. Arginine interacts with some key amino 
acids in specific ways. Arginine can both be synthesized from and play a role in synthesis of 
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citrulline; during times of low protein citrulline can be recycled to provide more arginine to the 
animal (Cynober, 2002). Citrulline supplementation has been shown to increase plasma arginine, 
and is relatively bioavailable (Cynober, 2007). Arginine can also synthesize ornithine in the gut 
via arginases, and ornithine can in turn synthesize polyamines downstream (Cynober, 2002; 
Flynn et al., 2002). Polyamines also play important roles in pregnancy due to their regulation of 
angiogenesis and embryonic development (Kwon et al., 2003). Lysine and histidine can have an 
antagonist relationship with arginine due to competition for the same y
+
 intestinal transporter 
(Flynn et al., 2002; Wu et al., 2009). Most of this lysine research has been performed in chicks, 
as chicks cannot synthesize arginine to correct this imbalance. Chicks supplemented with lysine 
have shown decreased growth rate, symptoms of arginine deficiency, and decreased plasma 
arginine concentrations due to an increase in arginine requirements (Jones et al., 1967). These 
results have been mixed in other studies, as most mammals can synthesize arginine from 
citrulline to counteract this imbalance. 
The objectives of this study are to evaluate the ability of rumen-protected arginine 
supplementation to positively impact carotid arterial hemodynamics during gestation. To aid in 
this, we also evaluated circulating amino acids in both pregnant dams and their offspring. We 
hypothesize that arginine supplementation will cause increased circulating arginine in 
supplemented ewes, along with increased ornithine and citrulline and decreased lysine. We 
further hypothesize that arginine supplementation will cause increased distal tissue blood 
perfusion and decreased resistance to vascular flow. 
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Materials and methods 
Animals 
Protocols described herein were approved by the North Dakota State University 
Institutional Animal Care and Use Committee. Multiparous Rambouillet-cross ewe lambs (n = 
32; 67.7 ± 6.2 kg initial BW) from NDSU Hettinger Research Extension Center were housed 
individually in a temperature-controlled facility (12 to 21°C; Animal Nutrition and Physiology 
Center; Fargo, ND) with free access to water. Facility lighting was timed to mimic normal 
daylight patterns. 
 
Experimental design and treatments 
 These procedures are described in more detail in Chapter 3. Ewes were fed a complete 
pelleted diet daily at 0800 (Table 2.1; Chapter 2, same diet as previous study). Ewe BW was 
monitored weekly and BCS every two weeks (by two or three independent observers) to 
determine if dietary adjustments were needed. Dietary intake for each individual ewe was 
calculated based on BW and ME requirements, and adjusted appropriately based on nutritional 
treatment. Diets were analyzed for DM, ash, and CP following AOAC (1990), and NDF and 
ADF using an Ankom Fiber Analyzer (Ankom Technology, Fairport, NY). 
 Ewes were randomly assigned to one of three dietary treatments. Dietary treatments 
included 100% of dietary requirements (control, CON; based on NRC, 1985, 2007), 60% of 
control (restricted, RES), or RES with the addition of a rumen protected arginine (RP-ARG, 
Kemin Industries, Des Moines, IA) supplement (RES-ARG). The rumen-protected arginine dose 
was administered at 180 mg/kg BW based on previous research done by our lab (Meyer et al., 
2011b; also experiment described in Chapter 2), and delivered in a 50 g fine ground corn carrier 
 65 
  
fed before the pelleted feed. This supplement was only received by the RES-ARG ewes, however 
the 50 g of fine ground corn was received by all ewes regardless of treatment. 
 
Parturition and lamb management 
At parturition, lambing was closely monitored 24 h per day as lambs were separated from 
dams immediately post birth. We sought to eliminate any bias in development due to maternal 
lactation. Lambs continued to be reared independent of dams for the remainder of the study. 
These procedures were described in more detail in Chapter 3 of this thesis. 
There were four sets of twins (2 CON, 1 RES, and 1 RES-ARG). Two lambs died during 
the experiment of unrelated causes, one at 7 d (RES-ARG), and another at 45 d (RES). Their data 
were included in the analyses up to removal from the study.   
 
Doppler ultrasonography 
The procedure for Doppler ultrasound used in this experiment was followed using the 
same procedure described for the previous dose titration experiment in Chapter 2. Carotid arterial 
hemodynamics were evaluated using duplex B-mode and D-mode programs of the color Doppler 
ultrasound instrument (model SSD-3500; Aloka America, Wallingford, CT) with an attached 
5.0-MHz finger transducer probe (Aloka UST-672). Ultrasound assessments were obtained 
without use of anesthesia, beginning with a baseline measurement on d 50, followed by 
measurements on d 90 and 130 of gestation. All scans were performed 10 cm below the 
mandible on the left carotid artery after shearing of wool and cleaning of the affected area. 
Aquasonic transmission gel (Parker Laboratories, Fairfield, NJ) was utilized as needed.  
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A cross-sectional view of the carotid artery was visualized first using B mode, and 
arterial pulsatility was confirmed using a duplex view of B-mode and D-mode. By using B-mode 
for visualization while simultaneously using D-mode for recording pulsatile waves, duplex mode 
was also used to obtain final hemodynamic measurements.  
As described in Lemley et al., 2012, three separate ultrasonography assessments yielding 
three analogous cardiac cycle waveforms were used to average hemodynamics for each ewe 
within a gestational day (9 measurements per day). Hemodynamic measurements were calculated 
using peak systolic velocity (PSV), end-diastolic velocity (EDV), mean velocity (MnV), and 
cross-sectional area of the vessel (CSA). These parameters were used to calculate final 
hemodynamic measurements including pulsatility index (PI; PI = [PSV (cm/s) – EDV 
(cm/s)]/MnV (cm/s)), an indicator of tissue blood perfusion, and resistance index (RI; RI = [PSV 
(cm/s) – EDV (cm/s)]/PSV (cm/s)), an indicator of vascular resistance. 
 
Blood sample collection and analysis 
Blood samples from dams were attained via right jugular venipuncture (to avoid 
puncturing the left carotid artery used for Doppler ultrasonography) at 0700 on d 54, 82, 110, 
138, of gestation, and immediately following parturition. Blood was collected from lambs 
immediately post birth, and at d 3, 7, 33, and 54 of age.  
All samples were collected in 10 mL Corvac serum separator vacuum tubes with 
thrombin (Tyco Healthcare, Mansfield, MA), which were placed on ice immediately post sample 
collection and held a minimum of 45 minutes to permit clotting. Whole blood samples were 
centrifuged for 30 minutes at 1,500 × g at 4°C. Following centrifugation supernatant was 
pipetted into 2-mL screw-cap vials and stored at 20°C. 
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Amino acid concentrations in serum were determined using ultra performance liquid 
chromatography (UPLC) methods similar to Meyer et al., 2011a, and the analysis performed in 
the previous experiment in Chapter 2 of this thesis. 
 
Statistical analysis 
 Amino acid concentrations in both ewes and lambs along with Doppler measurements 
were analyzed as repeated measures over time using the MIXED procedure if SAS (SAS Inst. 
Inc., Cary, NC). The factors measured included maternal dietary treatment, d of gestation, and 
interactions between treatment and d of gestation. Ante-dependence was used to appropriately 
describe the covariate structure. After protection with an overall F-test for treatment (P ≤ 0.10) 
means were separated using the method of least significant difference and statistical procedures 
of SAS and P - values ≤ 0.05 were considered different.   
 
Results and discussion 
Ewe Doppler measurements 
Following our hypothesis that arginine will improve hemodynamics during gestation, we 
expected RES-ARG ewes to respond similarly to CON ewes, with RES ewes having a 
disadvantage in hemodynamic measurements. Contrary to our hypothesis, we did not see an 
effect (P ≥ 0.24; Table 4.1) on maternal carotid hemodynamics due to arginine supplementation. 
However, we did observe differences due to level of nutrition in PI measurements. Ewes 
receiving adequate nutrients (CON) had lower (P = 0.05) PI than both RES and RES-ARG ewes. 
This means that CON ewes had greater distal tissue perfusion than RES ewes, which follows our 
original hypothesis. Previous studies have noted that in at risk pregnancies similar to those of 
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RES ewes, essential blood flow alterations during gestation may not occur and offspring may 
suffer as a result (Reynolds et al., 2006). It was our thinking that arginine supplementation may 
induce these blood flow increases regardless of nutritional plane, but our data did not support this 
theory. 
It may seem most intuitive that blood flow to organs should increase as pregnancy 
progresses, but this is not necessarily the case for all individual tissues. Our data shows that as 
pregnancy progresses, PI, as measured in the carotid artery, increases (P < 0.001); this increase 
in PI was an effect of an increase in PSV (P < 0.001), EDV (P < 0.001), and MnV (P < 0.001). 
An increase in PI signifies a decrease in distal tissue perfusion; in the case of the carotid artery, 
the tissue of perfusion is the brain. This increase in PI despite arginine supplementation is 
contrary to previous data from our lab; in a previous study, rumen-protected arginine 
supplementation at 180 mg/kg BW to steers caused both decreased carotid PI and RI compared 
to those steers receiving no arginine supplement (CON), and therefore increased distal tissue 
perfusion with lowered vascular resistance (Meyer et al., 2011b). We hypothesize that the major 
difference between the previous study and our current study is the status of pregnancy; the 
arginine supplement could not overcome the effect of alterations in blood flow during pregnancy. 
Rosenfeld (1977) found that, in pregnant ewes, blood flow to the brain as a percentage of cardiac 
output decreases as pregnancy progresses, along with blood flow to the liver and kidney In 
contrast, blood flow to the uterus and mammary gland increases markedly as pregnancy 
progresses. Further, Rosenfeld found that since cardiac output as a whole increases throughout 
pregnancy, actual blood flow to the brain remains the same. In either case, blood flow to the 
brain did not increase in either our ewes or the ewes in Rosenfeld’s study.  
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In addition to PI and its components, we observed an increase across all treatments in 
flow volume (P < 0.001) and cardiac output (P < 0.001) throughout pregnancy, which is similar 
to what has been observed in pregnant ewes in previous studies (Rosenfeld et al., 1977). Similar 
to our current study, the previous steer study from our lab cited no change in flow volume and 
cardiac output due to arginine supplementation (Meyer et al., 2011b).
  
7
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Table 4.1. Influence of nutrient restriction and arginine supplementation on ewe carotid arterial hemodynamics throughout 
gestation 
  
 
Treatment
1 
 
 
Day of Pregnancy 
Treatment* 
Day of 
Pregnancy 
 
Item 
 
CON 
 
RES 
RES-
ARG 
 
SEM 
P - 
value 
 
50 
 
90 
 
130 
 
SEM 
P – 
value 
P – 
value 
Pulsatility 
index 
1.781
a 
2.034
b 
2.032
b 
0.0807 0.05 1.462
a 
2.136
b 
2.249
b 
0.0788 <0.001 0.17 
Resistance 
index 
0.671 0.755 0.674 0.0511 0.41 0.700 0.708 0.691 0.0429 0.38 0.53 
Peak systolic   
  velocity 
131.6 138.1 122.6 12.45 0.67 123.0
a 
118.3
a 
151.1
b 
12.43 <0.001 0.70 
End diastolic 
velocity 
42.9 44.7 39.7 4.00 0.66 36.6
a 
38.7
a 
52.0
b 
4.29 <0.001 0.66 
Mean velocity 53.6 49.0 43.8 4.11 0.24 61.1
a 
40.4
b 
44.8
b 
3.90 <0.001 0.85 
Cross-sectional  
  area 
0.27 0.28 0.27 0.020 0.77 0.27 0.27 0.28 0.016 0.78 0.87 
Flow volume 824 744 703 68.5 0.44 960
a 
623
b 
688
b 
61.5 <0.001 0.55 
Heart rate 94 94 84 7.0 0.50 94 89 90 6.9 0.80 0.66 
Stroke volume 8.8 8.7 8.4 0.80 0.93 10.3
a 
7.4
b 
8.2
b 
0.63 <0.001 0.70 
Cardiac output 0.82 0.73 0.70 0.067 0.41 0.95
a 
0.61
b 
0.68
b 
0.060 <0.001 0.56 
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 11); RES-ARG = restricted + 
arginine, 60% CON nutrients with rumen-protected arginine supplement (n = 10). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05) within main effect means. 
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Ewe circulating amino acids 
 As we hypothesized, throughout gestation RES-ARG ewes had significantly more (P = 
0.002; Figure 4.1) circulating citrulline than RES ewes. However, CON ewes had significantly 
more (P = 0.05; Figure 4.1) circulating citrulline throughout gestation than RES-ARG ewes. At 
parturition particularly, CON and RES-ARG ewes had similar (P = 0.29), while RES ewes had 
lower (P ≤ 0.03) circulating citrulline concentrations. Because of the much intertwined 
relationship between arginine and citrulline (Cynober, 2002), these results are not surprising. 
Since RES-ARG ewes are intermediate (CON > RES-ARG > RES; P = < 0.001) in circulating 
citrulline concentrations throughout gestation, this may signify more efficient arginine 
mobilization than CON ewes, which may be converting excesses of arginine to citrulline. Ewes 
receiving restricted nutrients (particularly protein) may be mobilizing citrulline to synthesize 
arginine where necessary. 
 Circulating ornithine concentrations were also different among treatments at specific 
points of gestation (P = 0.04; Figure 4.1). Despite CON ewes having greater (P ≤ 0.02) 
circulating ornithine than both RES and RES-ARG ewes at d 110 and d 138 of gestation, at 
parturition RES-ARG ewes had greater (P = 0.03) circulating ornithine than RES ewes, with 
CON ewes being intermediate to both (P ≥ 0.08). 
These differences in citrulline and ornithine may help to explain why we don’t see overall 
gestation differences (P = 0.17; Table 4.2) in circulating arginine concentrations among 
treatments. Because arginine can be metabolized to both ornithine and citrulline, we may be 
measuring effects of arginine which aren’t contributing the measurements of arginine itself, but 
measurements of ornithine or citrulline instead.  
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We did not see any effects of antagonism in circulating lysine or histidine concentrations 
throughout gestation among treatments in these ewes (P ≥ 0.13; Figure 4.2). This shows that the 
dose of arginine that we are providing (180 mg/kg) is not too potent to inhibit the animal’s 
ability to overcome the potential amino acid imbalance induced by supplementation. Also, we 
know that sheep have different amino acid metabolism capabilities than poultry, which is the 
primary species showing evidence of arginine/lysine antagonism. 
 
Table 4.2. Serum arginine concentrations in ewes supplemented with rumen-protected arginine 
from d 54 to term of gestation
1 
 Treatment  P - values 
 
 
d of 
gestation 
 
 
 
CON 
 
 
 
RES 
 
 
RES-
ARG 
 
 
 
SEM 
 
 
 
Trt 
 
d of 
gestat-
ion 
d of 
gestat-
ion 
*Trt 
54 183.47 192.61 208.44 18.722 0.17 <0.001 0.01 
82 139.34 127.67 126.76 7.400    
110 138.24 119.42 139.29 9.737    
138 183.96 144.86 148.12 8.162    
Parturition 124.17 106.50 125.65 9.655    
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 
11); RES-ARG = restricted + arginine, 60% CON nutrients with rumen-protected arginine 
supplement (n = 10). 
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Figure 4.1. Influence of nutrient restriction and arginine supplementation on serum 
concentrations of (A) citrulline and (B) ornithine, amino acids related to arginine metabolism. * 
= CON > RES, ** = CON > RES and RES-ARG, *** = CON and RES-ARG > RES, † = RES-
ARG > RES (Differences at P ≤ 0.05) 
* 
** 
† 
 ** 
*** 
** 
** 
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Figure 4.2. Influence of nutrient restriction and arginine supplementation on serum 
concentrations of (A) lysine and (B) histidine, potential amino acid transporter antagonists. * = 
RES-ARG > CON, ** = RES-ARG > CON and RES (Differences at P ≤ 0.05) 
 
* 
** 
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Lamb circulating amino acids 
 Differences in circulating arginine concentrations were observed among offspring from 
dams on different nutritional treatments at different ages (P = 0.04; Figure 4.3). At 24 h of age, 
lambs from CON dams had greater (P = 0.008) circulating arginine concentrations than lambs 
from RES dams, with lambs from RES-ARG dams intermediate to both (P ≥ 0.09). This agrees 
with previous data from Kwon et al. (2004), in which fetal plasma from ewes fed 50% of 
requirements from d 28 to d 135 of gestation had reduced amino acid concentrations (including 
arginine, citrulline, and ornithine) as compared to offspring from ewes fed 100% of requirements 
throughout gestation. This previous data suggests that our maternal arginine supplementation 
improved circulating amino acids in offspring from nutrient restricted dams. 
Strangely, it seems that offspring from RES ewes maintained arginine concentrations 
over time while offspring from CON ewes dropped in arginine concentration over time. At d 33 
of age, lambs from RES dams had greater (P = 0.03) circulating arginine concentrations than 
CON, while RES-ARG was intermediate to both (P ≥ 0.16; Figure 4.3). Also at d 33 of age, 
lambs from CON dams had greater (P ≤ 0.03; Table 4.3) circulating citrulline concentrations 
than lambs from both RES and RES-ARG dams. It is possible that the arginine in CON offspring 
was used to synthesize citrulline because it may have reached a point of excess.  
By d 54 of age, lambs from RES-ARG dams had greater (P = 0.02) circulating arginine 
concentrations than CON, while RES was intermediate to both (P ≥ 0.19; Figure 4.3). These 
trends over time seem to describe a more steady state metabolism of arginine in offspring from 
RES-ARG dams compared to the more volatile serum arginine concentration changes observed 
in offspring from RES or CON dams. This steady state metabolism could provide more 
advantageous use of arginine for vascular modulation and polyamine metabolism, therefore 
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potentially offering the offspring a more healthy life than offspring from at-risk nutritional 
pregnancies may normally have (Reynolds et al., 2006). In Chapter 3 of this thesis, I have 
described previous data from our lab that shows maternal arginine supplementation during 
gestation improves BW and ADG in offspring from nutrient restricted dams. A contributor to 
this effect could be more efficient amino acid metabolism in offspring induced by maternal 
supplementation.   
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Figure 4.3. Influence of maternal nutrient restriction and arginine supplementation on offspring serum arginine concentration over 
time. CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 11); RES-ARG = restricted + 
arginine, 60% CON nutrients with rumen-protected arginine supplement (n = 11). * = CON > RES, RES-ARG = CON and RES; ** = 
RES > CON, RES-ARG = CON and RES; *** = RES-ARG > CON, RES = CON and RES-ARG. Differences determined at P ≤ 0.05. 
 
 
* 
** 
*** 
  
 
7
8
 
Table 4.3. Serum amino acid concentrations in lambs from ewes supplemented with rumen-protected arginine from d 54 to 
term of gestation 
 Maternal Treatment  P - values 
Age CON RES RES-ARG SEM Trt Age Age*Trt 
 Ornithine serum concentration (µmole/L)     
d 0 75.84 64.67 74.98 6.435 0.17 <0.001 0.82 
d 1 30.54
 
28.52
 
24.12
 
4.655    
d 3 56.29 53.09 46.94 5.278    
d 7 54.63 45.10 47.43 4.858    
d 33 93.77
 
87.27
 
72.92
 
10.083    
d 54 91.41
 
76.76
 
76.05
 
8.963    
 Citrulline serum concentration (µmole/L)     
d 0 138.01 128.42 157.21 13.374 0.02 <0.001 0.05 
d 1 96.84 74.16 67.71 14.727    
d 3 418.58
a
 301.46
b
 366.43
ab
 29.979    
d 7 331.24 325.29 310.22 20.765    
d 33 350.71
a
 271.81
b
 281.89
b
 22.260    
d 54 355.79 282.18 322.94 32.109    
 Lysine serum concentration (µmole/L)     
d 0 34.30
ab
 33.04
a
 44.99
b
 3.958 0.84 <0.001 0.71 
d 1 43.84 37.77 34.57 4.644    
d 3 90.77
 
87.62
 
83.43
 
7.570    
d 7 99.27 96.35 91.61 7.949    
d 33 146.99
 
144.56
 
138.79
 
12.869    
d 54 168.46 163.19 175.37 14.722    
 Histidine serum concentration (µmole/L)     
d 0 53.26
 
51.82
 
55.08
 
6.120 0.80 <0.001 0.29 
d 1 77.30
a
 62.34
b
 61.21
b
 4.329    
d 3 80.27 84.19 79.64 6.038    
d 7 54.27 48.75 56.11 4.532    
d 33 50.10 55.24 54.81 3.666    
d 54 64.65 64.61 69.01 5.447    
1
CON = control, 100% NRC requirements (n = 11); RES = restricted, 60% CON nutrients (n = 11); RES-ARG = restricted + 
arginine, 60% CON nutrients with rumen-protected arginine supplement (n = 11). 
a, b
Means within a row with different superscripts differ (P ≤ 0.05). 
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Summary 
 Data from this study demonstrates that maternal arginine supplementation during the last 
two-thirds of gestation has potential to improve offspring amino acid metabolism for arginine 
and related amino acids. We noted a more steady state metabolism effect on fetal arginine over 
time in RES-ARG lambs as opposed to offspring from CON and RES ewes. However, we reject 
our hypothesis that arginine supplementation during gestation improves maternal carotid arterial 
hemodynamics in at-risk pregnancies. 
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CHAPTER 5. CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Arginine has been an amino acid at the center of biomedical research for justified 
reasons; its potential effects on blood flow and polyamine synthesis along with essential 
biological (especially reproductive and fetal development) processes have been well documented 
(Wu et al., 2009). Our goal was to establish a dietary supplementation protocol for gestating 
ruminants that would enhance life of offspring postnatally. 
 Our dose titration study (Chapter 2) left us confident that in ewes, 180 mg/kg BW is the 
most efficient dose tested for the ewe to metabolize and utilize the supplement to induce an 
effect on blood flow. We know from previous data in our lab (Meyer et al., 2011) that this same 
dose has been shown to be most appropriate for steers. Taken together these data indicated that 
180 mg/kg BW daily is the most effective level of rumen-protected arginine tested. 
 When we applied this dose to a pregnant ewe nutrient restriction model, we found novel 
data suggesting that dietary arginine supplementation to restricted nutrient dams can result in 
enhanced postnatal fetal growth, despite not improving maternal BW or BCS (chapter 3). This 
data had been previously supported via arginine injection to ewes (Lassala et al., 2010); 
however, not via dietary consumption, which is more practical in production settings.  
Taking our analyses a step further, we learned that the effects we saw based on 
supplementation regarding blood flow of non-pregnant ewes (Chapter 2) were not replicated in 
pregnant ewes (Chapter 4). The remarkable shift in blood flow during pregnancy (Rosenfeld et 
al., 1974; Rosenfeld, 1977; Reynolds et al., 2006) likely overshadowed any response from the 
arginine supplement. However, we did see that circulating serum arginine concentrations, along 
with related amino acids (citrulline, ornithine, lysine, and histidine), appeared to reflect more 
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efficient, steady-state metabolism in both ewes and their offspring. This could contribute to an 
enhancement in postnatal development of offspring. 
Because this supplement is novel and not yet commercially available, more research 
should be conducted to determine how this effect of enhanced fetal growth despite maternal 
undernutrition is occurring. Specifically, nutrient transporters in dams and offspring should be 
examined to see if this data supports the serum amino acid concentration data: do those arginine 
supplemented dams and offspring up regulate arginine transporters to enhance metabolism?  
In addition, the effect of this supplement in other ruminant species, especially cattle, 
should be studied. Does this supplement have the same effect across species, or only in sheep? 
Taking this a step forward, would arginine supplementation to pregnant mothers receiving 
inadequate nutrition help to encourage normal fetal development and postnatal life of human 
babies? In areas of the world where protein sources are scarce, specifically, should this amino 
acid be considered for supplementation to pregnant women? 
All of these are questions for researchers moving forward in arginine research to address. 
It is my hope that the data we collected may provide information for these potential studies in the 
future. 
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